<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceuticals (Basel)</journal-id><journal-id journal-id-type="publisher-id">pharmaceuticals</journal-id><journal-title-group><journal-title>Pharmaceuticals</journal-title></journal-title-group><issn pub-type="epub">1424-8247</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7694456</article-id><article-id pub-id-type="pmid">33171909</article-id><article-id pub-id-type="doi">10.3390/ph13110369</article-id><article-id pub-id-type="publisher-id">pharmaceuticals-13-00369</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Biofilm Inhibition and Eradication Properties of Medicinal Plant Essential Oils against Methicillin-Resistant <italic>Staphylococcus aureus</italic> Clinical Isolates</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5435-9268</contrib-id><name><surname>Ben Abdallah</surname><given-names>Fethi</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00369">1</xref><xref ref-type="aff" rid="af2-pharmaceuticals-13-00369">2</xref><xref rid="c1-pharmaceuticals-13-00369" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Lagha</surname><given-names>Rihab</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00369">1</xref><xref ref-type="aff" rid="af2-pharmaceuticals-13-00369">2</xref></contrib><contrib contrib-type="author"><name><surname>Gaber</surname><given-names>Ahmed</given-names></name><xref ref-type="aff" rid="af1-pharmaceuticals-13-00369">1</xref><xref ref-type="aff" rid="af3-pharmaceuticals-13-00369">3</xref></contrib></contrib-group><aff id="af1-pharmaceuticals-13-00369"><label>1</label>Department of Biology, College of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia; <email>rihab.k@tu.edu.sa</email> (R.L.); <email>a.gaber@tu.edu.sa</email> (A.G.)</aff><aff id="af2-pharmaceuticals-13-00369"><label>2</label>Unit&#x000e9; de Recherche, Virologie &#x00026; Strat&#x000e9;gies Antivirales, UR17ES30, Institut Sup&#x000e9;rieur de Biotechnologie, University of Monastir, Monastir 5000, Tunisia</aff><aff id="af3-pharmaceuticals-13-00369"><label>3</label>Department of Genetics, Faculty of Agriculture, Cairo University, Giza 12613, Egypt</aff><author-notes><corresp id="c1-pharmaceuticals-13-00369"><label>*</label>Correspondence: <email>fetyben@tu.edu.sa</email></corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>11</month><year>2020</year></pub-date><volume>13</volume><issue>11</issue><elocation-id>369</elocation-id><history><date date-type="received"><day>16</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>04</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Methicillin-resistant <italic>Staphylococcus aureus</italic> is a major human pathogen that poses a high risk to patients due to the development of biofilm. Biofilms, are complex biological systems difficult to treat by conventional antibiotic therapy, which contributes to &#x0003e;80% of humans infections. In this report, we examined the antibacterial activity of <italic>Origanum majorana</italic>, <italic>Rosmarinus officinalis</italic>, and <italic>Thymus zygis</italic> medicinal plant essential oils against MRSA clinical isolates using disc diffusion and MIC methods. Moreover, biofilm inhibition and eradication activities of oils were evaluated by crystal violet. Gas chromatography&#x02013;mass spectrometry analysis revealed variations between oils in terms of component numbers in addition to their percentages. Antibacterial activity testing showed a strong effect of these oils against MRSA isolates, and <italic>T. zygis</italic> had the highest activity succeeded by <italic>O. majorana</italic> and <italic>R. officinalis</italic>. Investigated oils demonstrated high biofilm inhibition and eradication actions, with the percentage of inhibition ranging from 10.20 to 95.91%, and the percentage of eradication ranging from 12.65 to 98.01%. <italic>O. majorana</italic> oil had the highest biofilm inhibition and eradication activities. Accordingly, oils revealed powerful antibacterial and antibiofilm activities against MRSA isolates and could be a good alternative for antibiotics substitution.</p></abstract><kwd-group><kwd>methicillin-resistant <italic>Staphylococcus aureus</italic></kwd><kwd>essential oils</kwd><kwd><italic>Origanum majorana</italic></kwd><kwd><italic>Rosmarinus officinalis</italic></kwd><kwd><italic>Thymus zygis</italic></kwd><kwd>antibacterial</kwd><kwd>biofilm inhibition and eradication</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceuticals-13-00369"><title>1. Introduction</title><p>Methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) is considered a principal human pathogen and the most common cause of nosocomial infections. MRSA causes several diseases ranging from skin and soft tissue infections to serious invasive infections such as pneumonia, bacteremia, endocarditis and osteomyelitis [<xref rid="B1-pharmaceuticals-13-00369" ref-type="bibr">1</xref>]. The number of MRSA infections, which are more frequently associated with mortality than other bacterial infections, has increased considerably over recent years. <italic>S. aureus</italic> carries 20&#x02013;40% mortality at 30 days despite appropriate treatment [<xref rid="B2-pharmaceuticals-13-00369" ref-type="bibr">2</xref>].</p><p>MRSA poses a high risk to patients due to the development of biofilm [<xref rid="B3-pharmaceuticals-13-00369" ref-type="bibr">3</xref>]. Biofilm is considered as major virulence factor and is an organized structure built by almost all bacteria that is composed of nucleic acids, lipids, proteins, and polysaccharides [<xref rid="B4-pharmaceuticals-13-00369" ref-type="bibr">4</xref>]. Biofilms contribute to &#x0003e;80% of human infections and <italic>S. aureus</italic> is considered as the leading species in biofilm-associated infections [<xref rid="B5-pharmaceuticals-13-00369" ref-type="bibr">5</xref>]. In Biofilm, MRSA like other bacteria, become more persistent in the host organism, environment, and medical surfaces, and show an increased resistance to antibiotics and host immune factors [<xref rid="B6-pharmaceuticals-13-00369" ref-type="bibr">6</xref>,<xref rid="B7-pharmaceuticals-13-00369" ref-type="bibr">7</xref>,<xref rid="B8-pharmaceuticals-13-00369" ref-type="bibr">8</xref>], which is an important medical problem. Therefore, the development of novel compounds to treat biofilm is urgently required; plant essentials oils (EOs) that act against bacterial biofilm are of great interest.</p><p>EOs are volatile compounds that have been used to combat a variety of infections during hundreds of years as a natural medicine. It has been shown that EOs possess several significant antimicrobial activities such as antibacterial, antiviral, antifungal, and anti-parasitic activities in addition to their antioxidant, antiseptic, and insecticidal properties [<xref rid="B9-pharmaceuticals-13-00369" ref-type="bibr">9</xref>,<xref rid="B10-pharmaceuticals-13-00369" ref-type="bibr">10</xref>].</p><p><italic>Rosmarinus officinalis</italic> L., <italic>Thymus zygis</italic> L., and <italic>Origanum majorana</italic> L. belong to the Lamiaceae family. EOs obtained from aerial parts of the flowering stage of these plants, have been reported for their antibacterial activities against <italic>S. aureus</italic> [<xref rid="B11-pharmaceuticals-13-00369" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceuticals-13-00369" ref-type="bibr">12</xref>] and their antibiofilm activities against uropathogenic <italic>E. coli</italic> [<xref rid="B13-pharmaceuticals-13-00369" ref-type="bibr">13</xref>]. Several reports have shown that tea tree, thyme, and peppermint EOs, are effective against planktonic [<xref rid="B14-pharmaceuticals-13-00369" ref-type="bibr">14</xref>] and biofilm [<xref rid="B15-pharmaceuticals-13-00369" ref-type="bibr">15</xref>,<xref rid="B16-pharmaceuticals-13-00369" ref-type="bibr">16</xref>] MRSA. In addition, C&#x000e1;ceres et al. [<xref rid="B17-pharmaceuticals-13-00369" ref-type="bibr">17</xref>] demonstrated high anti-biofilm activity of thymol-carvacrol-chemotype (II) oil from <italic>Lippia origanoides</italic> against <italic>E. coli</italic> and <italic>S. epidermidis</italic>. However, these oils did not alter the growth rate of planktonic bacteria. The antibacterial effect of EOs, which is manifested by alterations of the bacterial cell wall and cell membrane, depends of their chemical composition [<xref rid="B18-pharmaceuticals-13-00369" ref-type="bibr">18</xref>]. The cell membrane compositions play an important role in the high resistance of Gram-negative bacteria to EOs compared to Gram-positive [<xref rid="B19-pharmaceuticals-13-00369" ref-type="bibr">19</xref>]. The hydrophobic molecules penetrate easily into the cells due to cell wall structure in Gram-positive bacteria and act on the cell wall and within the cytoplasm [<xref rid="B20-pharmaceuticals-13-00369" ref-type="bibr">20</xref>].</p><p>This study aimed to investigate the antibacterial, biofilm inhibition, and eradication properties of <italic>O. majorana</italic>, <italic>R. officinalis</italic>, and <italic>T. zygis</italic> medicinal plants&#x02019; EOs against clinical methicillin-resistant <italic>Staphylococcus aureus</italic>.</p></sec><sec sec-type="results" id="sec2-pharmaceuticals-13-00369"><title>2. Results</title><sec id="sec2dot1-pharmaceuticals-13-00369"><title>2.1. Distribution of the MRSA Isolates</title><p>Thirty clinical MRSA isolates were collected from King Abdulaziz Specialist Hospital, Taif, Saudi Arabia. The isolates were obtained from infection sites: surgical site infection (SSI, <italic>n</italic> = 4), skin and soft tissue (SST, <italic>n</italic> = 12), blood (<italic>n</italic> = 1), nasal (<italic>n</italic> = 8) and burn (<italic>n</italic> = 5). The distribution of isolates based on the type of specimen is presented in <xref ref-type="fig" rid="pharmaceuticals-13-00369-f001">Figure 1</xref>.</p></sec><sec id="sec2dot2-pharmaceuticals-13-00369"><title>2.2. Chemical Composition of the Essential Oils</title><p><italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis&#x02019;</italic> EOs chemical compositions are summarized in <xref rid="pharmaceuticals-13-00369-t001" ref-type="table">Table 1</xref>. In total 37 components were detected in these oils: 10 compounds in <italic>R. officinalis</italic> and 31 compounds in each of <italic>O. majorana</italic> and <italic>T. zygis</italic>.</p><p>GC-MS results showed variations between these oils regarding the compound numbers and their percentages. The major constituents of <italic>O. majorana</italic> were terpinen-4-ol (25.9%), &#x003b3;-terpinene (16.9%), linalool (10.9%), sabinene (8%), and &#x003b1;-terpinene (7.7%); those of <italic>R. officinalis</italic> were &#x003b1;-pinene (37.7%), bornyl acetate (9.1%), camphene (7.3%), borneol (5.5%), verbenone (5.4%), camphor (5.2%), and 1,8-cineole (4.7%). However, the main components of <italic>T. zygis</italic> were linalool (39.7%), terpinen-4-ol (11.7%), &#x003b2;-myrcene (8.6%), and &#x003b3;-terpinene (7.6%).</p></sec><sec id="sec2dot3-pharmaceuticals-13-00369"><title>2.3. Antibacterial Activity of Essential Oils against MRSA</title><sec id="sec2dot3dot1-pharmaceuticals-13-00369"><title>2.3.1. Disc Diffusion</title><p>The antibacterial activity of EOs against MRSA isolates was assessed by the disc diffusion method (<xref rid="pharmaceuticals-13-00369-t002" ref-type="table">Table 2</xref>). <italic>T. zygis</italic> EO has shown strong inhibitory activity on 80% of the strains, succeeded by <italic>O. majorana</italic> and <italic>R. officinalis</italic> that demonstrated a strong inhibitory action on 53.33% and 16.66% of the isolates, respectively. Moreover, according to the high percentage of anti-MRSA activity, <italic>T. zygis</italic> and <italic>O. majorana&#x02019;</italic> EOs have a strong inhibitory action on 80% and 53.33% of the strains, respectively. However, <italic>R. officinalis</italic> had a slight inhibitory action on 46.66% of the strains. Thereby, <italic>T. zygis&#x02019;</italic> EO appeared as the EO with the highest antibacterial activity, succeeded by <italic>O. majorana</italic> and <italic>R. officinalis</italic>. According to the type of specimen, globally, the same result was found as detected in cases of total isolates. <italic>T. zygis</italic> was regarded as an EO with strong inhibitory activity, succeeded by <italic>O. majorana</italic> and <italic>R. officinalis</italic>.</p></sec><sec id="sec2dot3dot2-pharmaceuticals-13-00369"><title>2.3.2. Determination of MIC and MBC</title><p>Antibacterial activity of EOs was assessed by measuring MICs and MBCs for the 30 MRSA isolates and the reference strain. The values of MIC extended from 0.78 mg/mL to 1.56 mg/mL, while the MBC varied from 3.125 mg/mL to 12.5 mg/mL for <italic>O. majorana</italic> EO.</p><p>Concerning <italic>T. zygis</italic> EO, the MIC values ranged from 0.39 mg/mL to 0.78 mg/mL, while the MBC value was 3.125 mg/mL. However, The MIC values of <italic>R. officinalis</italic> varied from 0.78 mg/mL to 1.56 mg/mL, but the MBC value was 12.5 mg/mL. Compared to <italic>O. majorana</italic> and <italic>R. officinalis</italic>, <italic>T. zygis</italic> EO showed the greatest antibacterial activity against MRSA isolates. Person correlation (r) showed no significant correlation between the type of specimen and MICs of oils (<italic>p</italic> &#x0003e; 0.05).</p></sec></sec><sec id="sec2dot4-pharmaceuticals-13-00369"><title>2.4. Biofilm Formation</title><p>MRSA strains were tested for their potentialities to form biofilm on a polystyrene surface. <xref rid="pharmaceuticals-13-00369-t003" ref-type="table">Table 3</xref> indicated that 96.66% of the isolates were able to form biofilm and were distributed as follow: 40% were highly positive biofilm producers with OD570 values ranged from 1.175 to 3.635, and 56.66% were low-grade positive with OD570 values extended from 0.113 to 0.87. However, out of the 30 isolates only one strain was isolated from the nasal sample was biofilm negative. Reference <italic>S. aureus</italic> ATCC 25923 was considered as a highly positive biofilm producer. Analysis of variance (ANOVA) indicated that there is no significant effect of the specimen on biofilm formation (<italic>p</italic> &#x0003e; 0.05).</p></sec><sec id="sec2dot5-pharmaceuticals-13-00369"><title>2.5. Biofilm Inhibition Activity of Essentials Oils</title><p>Biofilm inhibitory activities of <italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis&#x02019;</italic> EOs are summarized in <xref rid="pharmaceuticals-13-00369-t004" ref-type="table">Table 4</xref>. MRSA isolates that showed a biofilm formation potential were selected for this investigation. In all, 29 isolates considered as highly positive biofilm and low-grade positive biofilm in addition to the reference strain were used.</p><p><italic>O. majorana</italic> EO demonstrated an antibiofilm activity on 89.66% of the isolates (26 strains) in addition to the reference strain. Among them, 11 isolates (39.93%) were passed from low-grade positive to biofilm negative, three highly positive biofilm isolates (10.34%) become low-grade positive, and one strain isolated from nasal samples was changed from highly positive to biofilm negative after treatment with <italic>O. majorana</italic> EO. The percentage of inhibition ranged from 10.29 to 95.91%.</p><p>Concerning <italic>R. officinalis</italic> EO, we detected an antibiofilm effect on 79.31% of the isolates (23 strains). Furthermore, two groups of five isolates (17.24%) were changed. The first group was varied from low-grade positive to biofilm negative, and the second group was passed from highly positive to low-grade positive. In addition, the same isolate that changed from highly positive to biofilm negative under <italic>O. majorana</italic> EO, also became biofilm negative under <italic>R. officinalis</italic> EO. The percentage of inhibition extended from 10.20 to 95.65%.</p><p>Antibiofilm activity of <italic>T. zygis</italic> was observed on 62.06% of the isolates (18 strains). The percentage of biofilm inhibition ranged from 11.67 to 91.48%. Moreover, three low-grade positive isolates (10.34%) were changed to biofilm negative, and four highly positive isolates (13.79%) become low-grade positive.</p><p>The outcomes of this study indicated that <italic>O. majorana</italic> EO had the greatest antibiofilm activity against MRSA isolates succeeded by <italic>R. officinalis</italic> and <italic>T. zygis</italic>.</p><p>Person correlation (r) indicated a non-significant correlation between MIC and antibiofilm of EOs (<italic>p</italic> &#x0003e; 0.05). ANOVA test showed a non-significant effect of the specimen on biofilm inhibition (<italic>p</italic> &#x0003e; 0.05).</p></sec><sec id="sec2dot6-pharmaceuticals-13-00369"><title>2.6. Biofilm Eradication Activity of Essentials Oils</title><p>The results of biofilm eradication activities of EOs are shown in <xref rid="pharmaceuticals-13-00369-t005" ref-type="table">Table 5</xref>. The same isolates selected for biofilm inhibitory investigation were used. <italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis</italic> EOs showed eradication activities on 41.37% (12 strains) of the MRSA isolates independently of the specimen, including the reference strain. The highest percentage of eradication was recorded with <italic>O. majorana</italic>. The percentage of eradication ranged from 18.31 to 98.01%, from 12.65 to 94.39%, and from 13.45 to 92.69%, respectively, for <italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis</italic> EOs.</p><p>Based on biofilm categories and under <italic>O. majorana</italic> EO, five isolates (17.24%) were changed from highly positive to low-grade positive. Furthermore, a low-grade positive (isolate number 6) and a highly positive (isolate number 14) strains became biofilm negative. For <italic>T. zygis</italic>, only isolates numbers 5 and 6 were changed from highly positive and low-grade positive respectively to biofilm negative after treatment, while, <italic>R. officinalis</italic> caused modifications on three isolates. Among them, a low-grade positive (isolate number 28) was changed to biofilm negative, and two highly positive (isolates number 5 and 10) became low-grade positive.</p><p>Person correlation (r) indicated a non-significant correlation between MIC and biofilm eradication of EOs (<italic>p</italic> &#x0003e; 0.05). ANOVA test showed a non-significant effect of the specimen on biofilm eradication (<italic>p</italic> &#x0003e; 0.05).</p></sec></sec><sec sec-type="discussion" id="sec3-pharmaceuticals-13-00369"><title>3. Discussion</title><p>Infection caused by MRSA is considered a major public health threat in many countries and MRSA remains the principal cause of hospital and community-acquired infections [<xref rid="B21-pharmaceuticals-13-00369" ref-type="bibr">21</xref>]. This bacterium is accountable for numerous infections related to remarkable morbidity and mortality [<xref rid="B22-pharmaceuticals-13-00369" ref-type="bibr">22</xref>], such as bacteremia, pneumonia, and skin, soft tissue, surgical site, and urinary tract infections [<xref rid="B23-pharmaceuticals-13-00369" ref-type="bibr">23</xref>,<xref rid="B24-pharmaceuticals-13-00369" ref-type="bibr">24</xref>]. This study was conducted on 30 clinical MRSA isolates and results showed variability in the prevalence of the isolates. Indeed, most of the strains (40%) were recovered from SST followed by nasal, burn, SSI, and blood. Akanbi et al. [<xref rid="B25-pharmaceuticals-13-00369" ref-type="bibr">25</xref>] showed that the majority of MRSA strains were isolated from blood, wound, and urine specimens. In addition, Ghebremedhin et al. [<xref rid="B26-pharmaceuticals-13-00369" ref-type="bibr">26</xref>] demonstrated that MRSA was most found in surgical wound infections, succeeded by eye swabs, skin and soft tissue infections.</p><p>The ability of MRSA to develop resistance to every antibiotic to which it is exposed makes it a problem to human health [<xref rid="B27-pharmaceuticals-13-00369" ref-type="bibr">27</xref>]. Thereby the development of novel compounds is of great importance. Medicinal plant EOs have been largely used as a natural medicine to combat bacteria, fungi, viruses, and other pathogens [<xref rid="B28-pharmaceuticals-13-00369" ref-type="bibr">28</xref>]. Until now, about 3000 EOs are known, among them 300 are important for industries such as pharmaceutical, food, agronomic, cosmetics, and fragrance. In this work, we investigated the potential antibacterial activities of <italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis</italic> medicinal plant EOs against MRSA clinical isolates by disc diffusion, MIC, and MBC techniques. The highest antibacterial activity was observed with <italic>T. zygis</italic>, followed by <italic>O. majorana</italic>, and <italic>R. officinalis</italic> EOs. This result is in agreement with the study of Lagha et al. [<xref rid="B13-pharmaceuticals-13-00369" ref-type="bibr">13</xref>], who showed that <italic>T. zygis</italic> possessed the strongest antimicrobial effect against uropathogenic <italic>E. coli</italic> in contrast to <italic>O. majorana</italic>, and <italic>R. officinalis</italic> EOs. According to biochemical composition, the greater effect of <italic>T. zygis</italic> is owing to linalool (39.7%), which has a strong effect against bacteria and fungi [<xref rid="B29-pharmaceuticals-13-00369" ref-type="bibr">29</xref>]. Regarding <italic>O. majorana</italic> EO, the antibacterial activity can be attributed to the monoterpene alcohol, terpinen-4-ol, as a major compound (25.9%) [<xref rid="B30-pharmaceuticals-13-00369" ref-type="bibr">30</xref>], which was found to be effective against MRSA [<xref rid="B31-pharmaceuticals-13-00369" ref-type="bibr">31</xref>]. According to Cordeiro et al. [<xref rid="B32-pharmaceuticals-13-00369" ref-type="bibr">32</xref>], terpinen-4-ol has a powerful antibacterial effect against <italic>S. aureus</italic>. This compound functions as a bactericidal by obstructing the synthesis of the cell wall. Moreover, other main components such as terpinen-4-ol (11.7%), &#x003b2;-myrcene (8.6%) and &#x003b3;-terpinene (7.6%) are present in <italic>T. zygis</italic> in addition to linalool (10.9%), &#x003b3;-terpinene (16.9%) and &#x003b1;-terpinene (7.7%) present in <italic>O. majorana</italic> may enhance the antibacterial effect of these oils. Concerning <italic>R. officinalis</italic> EO, which showed the lowest activity against MRSA isolates, its antibacterial activity may be related to &#x003b1;-pinene (37.7%) as a major constituent. The study of Leite et al. [<xref rid="B33-pharmaceuticals-13-00369" ref-type="bibr">33</xref>] showed antibacterial activity of &#x003b1;-pinene against <italic>S. aureus</italic> and <italic>S. epidermidis</italic>. Other reports [<xref rid="B34-pharmaceuticals-13-00369" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceuticals-13-00369" ref-type="bibr">35</xref>] revealed the antibacterial activity of some EOs against Gram-negative and Gram-positive bacteria when &#x003b1;-Pinene is the major constituent. However, Utegenova et al. [<xref rid="B36-pharmaceuticals-13-00369" ref-type="bibr">36</xref>] demonstrated that &#x003b1;-pinene had low activity against MRSA, indicating that other components were probably responsible. Among them, in this study, 1,8-cineole (4.7%) altered the structure of <italic>E. coli</italic>, <italic>S. enteritidis</italic>, and <italic>S. aureus</italic> [<xref rid="B37-pharmaceuticals-13-00369" ref-type="bibr">37</xref>]. The antibacterial activity of <italic>R. officinalis</italic> could be attributed to the synergistic effect of camphor (5.2%), verbenone (5.4%), and borneol (5.5%) in addition to &#x003b1;-pinene and 1,8-cineole [<xref rid="B38-pharmaceuticals-13-00369" ref-type="bibr">38</xref>]. In general, whole essential oils have an important antimicrobial effect compared to the major compounds individually or collectively. This suggests that minor constituents are essential and may have a synergistic antibacterial effect [<xref rid="B10-pharmaceuticals-13-00369" ref-type="bibr">10</xref>].</p><p>MRSA were tested for their capacities to produce biofilm on polystyrene microplates and results indicated that 40% of the strains were highly positive biofilm and 56.66% were low-grade positive. Out of the 30 isolates, only one strain was biofilm negative, which indicates the high potentiality of the isolates to form biofilm. Biofilm, as a virulence factor that favors the chronicity of <italic>S</italic>. <italic>aureus</italic> infections, is accountable for more 65% of nosocomial infections and 80% of microbial infections [<xref rid="B5-pharmaceuticals-13-00369" ref-type="bibr">5</xref>]. Biofilm is related to various staphylococcal diseases, such as skin and soft tissue infections, nasal colonization, endocarditis and urinary tract infections [<xref rid="B39-pharmaceuticals-13-00369" ref-type="bibr">39</xref>]. Further, biofilm becomes a serious threat in the urology field due to its responsibility for the long persistence of bacteria in the genitourinary tract [<xref rid="B40-pharmaceuticals-13-00369" ref-type="bibr">40</xref>]. The high ability of the investigated isolates to form biofilm confirms the fact that <italic>S. aureus</italic> is the leading species in biofilm-associated infection.</p><p>Biofilm has been associated with medical devices and its treatment is becoming increasingly difficult due to the resistance to antibiotics and the immune system in addition to the spread of infection [<xref rid="B39-pharmaceuticals-13-00369" ref-type="bibr">39</xref>]. Thereby, the development of new therapeutic strategies, such as EOs, to inhibit or eradicate biofilm is great of interest. In this work, biofilm inhibitory activity of EOs showed that <italic>O. majorana</italic> had the highest antibiofilm activity (antibiofilm effect on 89.66% of the isolates) against MRSA isolates followed by <italic>R. officinalis</italic> and <italic>T. zygis</italic> that demonstrated activity on 79.31 and 62.06% of the isolates, respectively. EOs also showed a strong potential to inhibit biofilm, with percentage of inhibition ranging from 10.29 to 95.91%, from 10.20 to 95.65%, and from 11.67 to 91.48%, respectively for <italic>O. majorana</italic>, <italic>R. officinalis</italic>, and <italic>T. zygis</italic>. Based on our results, the oil with the highest growth inhibition activity was different from the oil with the highest biofilm inhibition effect, which indicates that the components involved in growth inhibition were different from those associated with biofilm inhibition. According to biochemical specificity, terpinen-4-ol present in <italic>O. majorana</italic> as major compound, has more inhibition of the biofilm formation process by MRSA isolates compared to &#x003b1;-pinene and linalool present, as the main components, in <italic>R. officinalis</italic> and <italic>T. zygis</italic> EOs, respectively.</p><p>This finding corroborates the recent data of Cordeiro et al. [<xref rid="B32-pharmaceuticals-13-00369" ref-type="bibr">32</xref>] showing that the strongest antibiofilm activity of terpinen-4-ol was against <italic>S. aureus</italic>. Other studies have also demonstrated that this compound possesses an excellent potential against biofilm formed by some pathogenic bacteria like <italic>Pseudomonas aeruginosa</italic> [<xref rid="B41-pharmaceuticals-13-00369" ref-type="bibr">41</xref>], <italic>Streptococcus mutans</italic>, <italic>Lactobacillus acidophilus</italic> [<xref rid="B42-pharmaceuticals-13-00369" ref-type="bibr">42</xref>], <italic>Porphyromonas gingivalis</italic>, and Fusobacterium nucleatum [<xref rid="B43-pharmaceuticals-13-00369" ref-type="bibr">43</xref>]. Biofilm inhibition properties of <italic>O. majorana</italic>, <italic>R. officinalis</italic>, and <italic>T. zygis</italic> EOs against MRSA suggest that the addition of these oils before biofilm formation eliminates planktonic cells and may reduce the polystyrene surface adherence, which becomes less susceptible to cell adhesion. Additionally, the modification of MRSA surface proteins caused by their interactions with oils inhibits the adhesion of this bacterium to the polystyrene surface, which is the initial attachment phase [<xref rid="B44-pharmaceuticals-13-00369" ref-type="bibr">44</xref>].</p><p>Preformed biofilms are difficult to eradicate by conventional antibiotic therapy. However, in the present study, <italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis</italic> EOs showed high biofilm eradication activities on 41.37% of the MRSA isolates. <italic>O. majorana</italic> EO had the strongest effect, with the percentage of eradication going up to 98.01%, and seven isolates were changed their biofilm phenotype. It seems that the monoterpenoid terpinen-4-ol has an excellent potential to eradicate mature biofilm than &#x003b1;-pinene and linalool. The activity of these oils on mature biofilms was lower than their capacity to inhibit the formation of biofilms. This can be explained by the fact that the major constituents in these oils have an effect on the biofilm formation process more than on mature biofilm. This is in agreement with the report of Cordeiro et al. [<xref rid="B32-pharmaceuticals-13-00369" ref-type="bibr">32</xref>], showing that terpinen-4-ol is more efficient in inhibiting the formation of <italic>S. aureus</italic> biofilms than in breaking or eliminating mature biofilms. Many EOs, such as tea tree [<xref rid="B45-pharmaceuticals-13-00369" ref-type="bibr">45</xref>], eucalyptus [<xref rid="B46-pharmaceuticals-13-00369" ref-type="bibr">46</xref>], and cinnamon oil [<xref rid="B47-pharmaceuticals-13-00369" ref-type="bibr">47</xref>] have shown their effective ability to remove biofilm. Moreover, <italic>R. officinalis</italic> EO has reduced the quantity of <italic>S. aureus</italic> biofilm to 60.76% [<xref rid="B48-pharmaceuticals-13-00369" ref-type="bibr">48</xref>]. In general, EOs diffuse through polysaccharide matrix of the preformed biofilm and destabilize it because of higher intrinsic antimicrobial activities [<xref rid="B44-pharmaceuticals-13-00369" ref-type="bibr">44</xref>].</p></sec><sec id="sec4-pharmaceuticals-13-00369"><title>4. Materials and Methods</title><sec id="sec4dot1-pharmaceuticals-13-00369"><title>4.1. Bacterial Strains</title><p>Thirty clinical MRSA isolates were collected from King Abdulaziz Specialist Hospital, Taif, Saudi Arabia. The isolates were identified as <italic>S. aureus</italic>, as described previously [<xref rid="B49-pharmaceuticals-13-00369" ref-type="bibr">49</xref>]. The methicillin resistance phenotype was performed by the Vitek 2 system (bioM&#x000e9;rieux, Durham, North CA, USA) in accordance with the British Society for Antimicrobial Chemotherapy (BSAC). Each isolate was considered as methicillin-resistant when the minimum inhibitory concentration (MIC) breakpoint of oxacillin was &#x0003e;2 mg/L and cefoxitin &#x0003e;4 mg/L. [<xref rid="B50-pharmaceuticals-13-00369" ref-type="bibr">50</xref>]. <italic>S. aureus</italic> ATCC 25922 was used as control.</p></sec><sec id="sec4dot2-pharmaceuticals-13-00369"><title>4.2. Medicinal Plants Essential Oils</title><p>Three commercial EOs extracted from medicinal plants were investigated. These EOs were bought from Laboratoires OMEGA Pharma (Groupe Perrigo)&#x02014;Phytosun Ar&#x000f4;ms (Ch&#x000e2;tillon, France) and kept at 4 &#x000b0;C in dark glass bottles till used. These oils were extracted from twigs of <italic>R. officinalis</italic> L. (M14302), and from the aerial parts of flowering stage of <italic>T. zygis</italic> L. subsp. <italic>zygis</italic> (M13184) and <italic>O. majorana</italic> L. (74K100C6). These EOs were carefully chosen for their antibacterial and/or antibiofilm actions, as stated previously [<xref rid="B11-pharmaceuticals-13-00369" ref-type="bibr">11</xref>,<xref rid="B12-pharmaceuticals-13-00369" ref-type="bibr">12</xref>,<xref rid="B13-pharmaceuticals-13-00369" ref-type="bibr">13</xref>] and their usage in traditional medicine.</p></sec><sec id="sec4dot3-pharmaceuticals-13-00369"><title>4.3. Gas Chromatography&#x02014;Mass Spectrometry Analysis</title><p>The GC-MS analysis was performed as described previously [<xref rid="B51-pharmaceuticals-13-00369" ref-type="bibr">51</xref>].</p></sec><sec id="sec4dot4-pharmaceuticals-13-00369"><title>4.4. Antibacterial Activity of Essential Oils</title><sec id="sec4dot4dot1-pharmaceuticals-13-00369"><title>4.4.1. Disc Diffusion</title><p>The agar disc diffusion method was used to evaluate the antibacterial activities of the EOs [<xref rid="B52-pharmaceuticals-13-00369" ref-type="bibr">52</xref>]. Briefly, an overnight cultures of MRSA cells grown at 37 &#x000b0;C were diluted to a density of 0.5 McFarland standards turbidity (DENSIMAT, Bio-merieux, Marcy l&#x02019;Etoile, France) and were streaked onto Mueller&#x02013;Hinton agar (MHA) plates using a sterile swab. A sterile filter disc (diameter 6 mm) was placed and then was impregnated by <italic>R. officinalis</italic>, <italic>T. zygis</italic>, and <italic>O. majorana</italic> EOs (10 &#x003bc;L /disc). The plates were maintained at 4 &#x000b0;C for 2 h and then incubated at 37 &#x000b0;C for 24 h. After incubation, the antibacterial activity was evaluated by determining the zone of growth inhibition throughout the discs.</p><p>Inhibitory action was categorized according to the zone of inhibition (ZI) as described previously [<xref rid="B13-pharmaceuticals-13-00369" ref-type="bibr">13</xref>,<xref rid="B14-pharmaceuticals-13-00369" ref-type="bibr">14</xref>,<xref rid="B15-pharmaceuticals-13-00369" ref-type="bibr">15</xref>,<xref rid="B16-pharmaceuticals-13-00369" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceuticals-13-00369" ref-type="bibr">17</xref>,<xref rid="B18-pharmaceuticals-13-00369" ref-type="bibr">18</xref>,<xref rid="B19-pharmaceuticals-13-00369" ref-type="bibr">19</xref>,<xref rid="B20-pharmaceuticals-13-00369" ref-type="bibr">20</xref>,<xref rid="B21-pharmaceuticals-13-00369" ref-type="bibr">21</xref>,<xref rid="B22-pharmaceuticals-13-00369" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceuticals-13-00369" ref-type="bibr">23</xref>,<xref rid="B24-pharmaceuticals-13-00369" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceuticals-13-00369" ref-type="bibr">25</xref>,<xref rid="B26-pharmaceuticals-13-00369" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceuticals-13-00369" ref-type="bibr">27</xref>,<xref rid="B28-pharmaceuticals-13-00369" ref-type="bibr">28</xref>,<xref rid="B29-pharmaceuticals-13-00369" ref-type="bibr">29</xref>,<xref rid="B30-pharmaceuticals-13-00369" ref-type="bibr">30</xref>,<xref rid="B31-pharmaceuticals-13-00369" ref-type="bibr">31</xref>,<xref rid="B32-pharmaceuticals-13-00369" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceuticals-13-00369" ref-type="bibr">33</xref>,<xref rid="B34-pharmaceuticals-13-00369" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceuticals-13-00369" ref-type="bibr">35</xref>,<xref rid="B36-pharmaceuticals-13-00369" ref-type="bibr">36</xref>,<xref rid="B37-pharmaceuticals-13-00369" ref-type="bibr">37</xref>,<xref rid="B38-pharmaceuticals-13-00369" ref-type="bibr">38</xref>,<xref rid="B39-pharmaceuticals-13-00369" ref-type="bibr">39</xref>,<xref rid="B40-pharmaceuticals-13-00369" ref-type="bibr">40</xref>,<xref rid="B41-pharmaceuticals-13-00369" ref-type="bibr">41</xref>,<xref rid="B42-pharmaceuticals-13-00369" ref-type="bibr">42</xref>,<xref rid="B43-pharmaceuticals-13-00369" ref-type="bibr">43</xref>,<xref rid="B44-pharmaceuticals-13-00369" ref-type="bibr">44</xref>,<xref rid="B45-pharmaceuticals-13-00369" ref-type="bibr">45</xref>,<xref rid="B46-pharmaceuticals-13-00369" ref-type="bibr">46</xref>,<xref rid="B47-pharmaceuticals-13-00369" ref-type="bibr">47</xref>,<xref rid="B48-pharmaceuticals-13-00369" ref-type="bibr">48</xref>,<xref rid="B49-pharmaceuticals-13-00369" ref-type="bibr">49</xref>,<xref rid="B50-pharmaceuticals-13-00369" ref-type="bibr">50</xref>,<xref rid="B51-pharmaceuticals-13-00369" ref-type="bibr">51</xref>,<xref rid="B52-pharmaceuticals-13-00369" ref-type="bibr">52</xref>,<xref rid="B53-pharmaceuticals-13-00369" ref-type="bibr">53</xref>]. The experiment was performed in triplicate, and the mean diameter of the inhibition zone was documented.</p></sec><sec id="sec4dot4dot2-pharmaceuticals-13-00369"><title>4.4.2. Minimum Inhibitory Concentration and Minimum Bactericidal Concentration</title><p>The minimal inhibition concentration (MIC) and the minimal bactericidal concentration (MBC) were assessed in triplicates on 96-well microtiter plates (Nunc, Roskilde, Denmark) as described previously [<xref rid="B54-pharmaceuticals-13-00369" ref-type="bibr">54</xref>]. A bacterial suspension at a density of 0.5 McFarland standards turbidity was prepared from an overnight culture. Then, a serial two-fold dilution for each EOs (50 mg/mL stock solution) was made in 5 mL of nutrient broth with concentration ranged from 0.012&#x02013;50 mg/mL.</p><p>Each well of the 96-well plates contains 95 &#x003bc;L of nutrient broth and 5 &#x003bc;L of the bacterial inoculum. A 100 &#x003bc;L aliquot from the stock solutions of each EO was added into the first well. Then, 100 &#x003bc;L from the serial dilutions were transferred into the consecutive well. The negative control well contains 195 &#x003bc;L of nutrient broth without EO and 5 &#x003bc;L of the bacterial inoculum. The final volume in each well was 200 &#x003bc;L, and the plates were incubated at 37 &#x000b0;C for 18&#x02013;24 h.</p><p>The MIC was defined as the lowest concentration of the EO at which the MRSA cells growth is inhibited. The MBC was determined by subculturing 20 &#x003bc;L from clear wells of the MIC test on MHA. MBC was defined as the lowest concentration of EOs, required to kill &#x02265;99.9% of the initial bacterial inoculum [<xref rid="B55-pharmaceuticals-13-00369" ref-type="bibr">55</xref>].</p></sec></sec><sec id="sec4dot5-pharmaceuticals-13-00369"><title>4.5. Biofilm Formation</title><p>Biofilm formation by MRSA isolates was determined using crystal violet assay on U-bottomed 96-well microtiter plates, as detailed previously [<xref rid="B56-pharmaceuticals-13-00369" ref-type="bibr">56</xref>]. Each MRSA strain was tested three times. Wells with sterile TSB only were worked as controls. The optical density of each well was measured at 570 nm (OD570) using an automated Multiskan reader (GIO. DE VITA E C, Rome, Italy). Biofilm formation was interpreted as highly positive (OD570 &#x02265; 1), low-grade positive (0.1 &#x02264; OD570 &#x0003c; 1), or negative (OD570 &#x0003c; 0.1).</p></sec><sec id="sec4dot6-pharmaceuticals-13-00369"><title>4.6. Biofilm Inhibition</title><p>EOs were tested for their potential to prevent biofilm formation by MRSA isolates. For the experiment, 100 &#x000b5;L of the EOs emulsified in TSB supplement with 2% glucose were put in the U-bottomed 96-well microtiter plate, including 100 &#x003bc;L of bacterial suspensions (10<sup>8</sup> CFU/mL) in each well. The final concentrations of the EOs were equal to MIC, and the final volume was 200 &#x003bc;L per well. The analyzes were performed three times. After incubation of microplates at 37 &#x000b0;C for 24 h, the formed biofilm was measured by crystal violet as described previously [<xref rid="B56-pharmaceuticals-13-00369" ref-type="bibr">56</xref>]. For the Controls wells, the inoculums volume and EOs were replaced by TSB and sterile water, respectively. Inhibition of biofilm was determined from the formula described by Jadhav et al. [<xref rid="B57-pharmaceuticals-13-00369" ref-type="bibr">57</xref>].
<disp-formula id="FD1-pharmaceuticals-13-00369"><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mo>%</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mi>Inhibition</mml:mi><mml:mo>&#x000a0;</mml:mo><mml:mo>=</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mn>100</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>OD</mml:mi><mml:mn>570</mml:mn><mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mi>sample</mml:mi></mml:mrow></mml:mrow><mml:mrow><mml:mi>OD</mml:mi><mml:mn>570</mml:mn><mml:mrow><mml:mo>&#x000a0;</mml:mo><mml:mi>control</mml:mi></mml:mrow></mml:mrow></mml:mfrac><mml:mo>&#x000a0;</mml:mo><mml:mo>&#x000d7;</mml:mo><mml:mo>&#x000a0;</mml:mo><mml:mn>100</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec4dot7-pharmaceuticals-13-00369"><title>4.7. Biofilm Eradication</title><p>In order to eradicate the preformed biofilm at the maturation stage (48 h biofilms), the plates were incubated for 48 h, the medium was changed after 24 h, and EOs were added at the same concentrations and at the last 24 h. Biofilms formed by bacteria that did not undergo any treatment were used as controls. Experimentally, the plates were incubated for 24 h at 37 &#x000b0;C to allow for biofilm attachment and growth. The following day, the non-adhered cells were removed from each well, and the adhered biofilm was rinsed two times with PBS. Then, 200 &#x000b5;L of TSB (2% glucose) with final concentrations of the EOs equivalent to MIC was added, and the plates were incubated for 24 h [<xref rid="B44-pharmaceuticals-13-00369" ref-type="bibr">44</xref>]. The biofilm was assessed by crystal violet, and eradication of biofilm was calculated as described in <xref ref-type="sec" rid="sec4dot6-pharmaceuticals-13-00369">Section 4.6</xref>. The experiment was carried out in triplicate.</p></sec><sec id="sec4dot8-pharmaceuticals-13-00369"><title>4.8. Statistical Analysis</title><p>Statistical analysis was performed using analysis of variance (ANOVA). Pearson&#x02019;s simple linear correlation coefficient (r) and their significance (<italic>p</italic>) were assessed using IBM SPSS (v20).</p></sec></sec><sec sec-type="conclusions" id="sec5-pharmaceuticals-13-00369"><title>5. Conclusions</title><p>The outcomes of this study support the medical application of <italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis</italic> EOs for the prevention and/or treatment of MRSA infections and diseases as an alternative to or combined with antibiotics. These EOs, provided from Laboratoires OMEGA Pharma&#x02013;Phytosun Ar&#x000f4;ms (Ch&#x000e2;tillon, France), are used orally and in high concentrations (doses), corroborating their non-toxic effect. Generally, the therapeutic application of EOs is limited by their solubility, skin-sensitization synonymous allergic contact dermatitis, and their physicochemical stability due to the volatile components and the conversion of components by cyclization, isomerization, oxidation, or dehydrogenation reactions. Further adequate in vitro testing or in vivo preclinical experiments are warranted to establish safety, efficacy, potential adverse effects, and interaction with other drugs of <italic>O. majorana</italic>, <italic>T. zygis</italic>, and <italic>R. officinalis</italic> EOs before including them in clinical practice.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors are thankful to Taif University for supplying essential facilities and acknowledge the support of Taif University Researchers Supporting Project number (TURSP-2020/39), Taif University, Taif, Saudi Arabia.</p></ack><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>F.B.A. conceived and designed the experiments; F.B.A. and R.L. performed the experiments; A.G. funding acquisition; F.B.A. writing&#x02014;review and editing. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>The authors appreciated Taif University Researchers Supporting Project number (TURSP-2020/39), Taif University, Taif, Saudi Arabia.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pharmaceuticals-13-00369"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>R.J.</given-names></name><name><surname>Lowy</surname><given-names>F.D.</given-names></name></person-group><article-title>Pathogenesis of methicillin-resistant <italic>Staphylococcus aureus</italic> infection</article-title><source>Clin. Infect. Dis.</source><year>2008</year><volume>46</volume><fpage>S350</fpage><lpage>S359</lpage><?supplied-pmid 18462090?><pub-id pub-id-type="pmid">18462090</pub-id></element-citation></ref><ref id="B2-pharmaceuticals-13-00369"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melzer</surname><given-names>M.</given-names></name><name><surname>Welch</surname><given-names>C.</given-names></name></person-group><article-title>Tirty-day mortality in UK patients with community-onset and hospital-acquired methicillin susceptible <italic>Staphylococcus aureus</italic> bacteraemia</article-title><source>J. Hosp. Infect.</source><year>2013</year><volume>84</volume><fpage>143</fpage><lpage>150</lpage><?supplied-pmid 23602415?><pub-id pub-id-type="pmid">23602415</pub-id></element-citation></ref><ref id="B3-pharmaceuticals-13-00369"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doebbeling</surname><given-names>B.</given-names></name></person-group><article-title>The epidemiology of methicillin-resistant <italic>Staphylococcus aureus</italic> colonisation and infection</article-title><source>J. Chemother.</source><year>1995</year><volume>7</volume><fpage>99</fpage><lpage>103</lpage><?supplied-pmid 8609545?><pub-id pub-id-type="pmid">8609545</pub-id></element-citation></ref><ref id="B4-pharmaceuticals-13-00369"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall-Stoodley</surname><given-names>L.</given-names></name><name><surname>Costerton</surname><given-names>J.W.</given-names></name><name><surname>Stoodley</surname><given-names>P.</given-names></name></person-group><article-title>Bacterial biofilms: From the natural environment to infectious diseases</article-title><source>Nat. Rev. Microbiol.</source><year>2004</year><volume>2</volume><fpage>95</fpage><lpage>108</lpage><?supplied-pmid 15040259?><pub-id pub-id-type="pmid">15040259</pub-id></element-citation></ref><ref id="B5-pharmaceuticals-13-00369"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000f6;mling</surname><given-names>U.</given-names></name><name><surname>Balsalobre</surname><given-names>C.</given-names></name></person-group><article-title>Biofilm infections, their resilience to therapy and innovative treatment strategies</article-title><source>J. Intern. Med.</source><year>2012</year><volume>272</volume><fpage>541</fpage><lpage>561</lpage><?supplied-pmid 23025745?><pub-id pub-id-type="pmid">23025745</pub-id></element-citation></ref><ref id="B6-pharmaceuticals-13-00369"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoes</surname><given-names>M.</given-names></name><name><surname>Bennett</surname><given-names>R.N.</given-names></name><name><surname>Rosa</surname><given-names>E.A.S.</given-names></name></person-group><article-title>Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>746</fpage><lpage>757</lpage><?supplied-pmid 19471683?><pub-id pub-id-type="pmid">19471683</pub-id></element-citation></ref><ref id="B7-pharmaceuticals-13-00369"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costerton</surname><given-names>J.W.</given-names></name><name><surname>Stewart</surname><given-names>P.S.</given-names></name><name><surname>Greenberg</surname><given-names>E.P.</given-names></name></person-group><article-title>Bacterial biofilms: A common cause of persistent infections</article-title><source>Science</source><year>1999</year><volume>284</volume><fpage>1318</fpage><lpage>1322</lpage><pub-id pub-id-type="pmid">10334980</pub-id></element-citation></ref><ref id="B8-pharmaceuticals-13-00369"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>P.S.</given-names></name></person-group><article-title>Mechanisms of antibiotic resistance in bacterial biofilms</article-title><source>Int. J. Med. Microbiol.</source><year>2002</year><volume>292</volume><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">12195733</pub-id></element-citation></ref><ref id="B9-pharmaceuticals-13-00369"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebadollahi</surname><given-names>A.</given-names></name><name><surname>Ziaee</surname><given-names>M.</given-names></name><name><surname>Palla</surname><given-names>F.</given-names></name></person-group><article-title>Essential oils extracted from different species of the <italic>Lamiaceae</italic> plant family as prospective bioagents against several detrimental pests</article-title><source>Molecules</source><year>2020</year><volume>25</volume><fpage>1556</fpage></element-citation></ref><ref id="B10-pharmaceuticals-13-00369"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>S.</given-names></name></person-group><article-title>Essential oils: Their antibacterial properties and potential applications in foods&#x02014;A review</article-title><source>Int. J. Food Microbiol.</source><year>2004</year><volume>94</volume><fpage>223</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">15246235</pub-id></element-citation></ref><ref id="B11-pharmaceuticals-13-00369"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rota</surname><given-names>M.C.</given-names></name><name><surname>Herrera</surname><given-names>A.</given-names></name><name><surname>Martinez</surname><given-names>R.M.</given-names></name><name><surname>Sotomayor</surname><given-names>J.A.</given-names></name><name><surname>Jordan</surname><given-names>M.J.</given-names></name></person-group><article-title>Antimicrobial activity and chemical composition of <italic>Thymus vulgaris</italic>, <italic>Thymus zygis</italic>, and <italic>Thymus hyemalis</italic> essential oils</article-title><source>Food Control</source><year>2008</year><volume>19</volume><fpage>681</fpage><lpage>687</lpage></element-citation></ref><ref id="B12-pharmaceuticals-13-00369"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moumni</surname><given-names>S.</given-names></name><name><surname>Elaissi</surname><given-names>A.</given-names></name><name><surname>Trabelsi</surname><given-names>A.</given-names></name><name><surname>Merghni</surname><given-names>A.</given-names></name><name><surname>Chraief</surname><given-names>I.</given-names></name><name><surname>Jelassi</surname><given-names>B.</given-names></name><name><surname>Chemli</surname><given-names>R.</given-names></name><name><surname>Ferchichi</surname><given-names>S.</given-names></name></person-group><article-title>Correlation between chemical composition and antibacterial activity of some <italic>Lamiaceae</italic> species essential oils from Tunisia</article-title><source>BMC Complement Med. Ther.</source><year>2020</year><volume>20</volume><elocation-id>103</elocation-id><pub-id pub-id-type="pmid">32245466</pub-id></element-citation></ref><ref id="B13-pharmaceuticals-13-00369"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagha</surname><given-names>R.</given-names></name><name><surname>Ben Abdallah</surname><given-names>F.</given-names></name><name><surname>AL-Sarhan</surname><given-names>B.O.</given-names></name><name><surname>Al-Sodany</surname><given-names>Y.</given-names></name></person-group><article-title>Antibacterial and Biofilm Inhibitory Activity of Medicinal Plant Essential Oils against <italic>Escherichia coli</italic> Isolated from UTI Patients</article-title><source>Molecules</source><year>2019</year><volume>23</volume><fpage>1161</fpage></element-citation></ref><ref id="B14-pharmaceuticals-13-00369"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nostro</surname><given-names>A.</given-names></name><name><surname>Blanco</surname><given-names>A.R.</given-names></name><name><surname>Cannatelli</surname><given-names>M.A.</given-names></name><name><surname>Enea</surname><given-names>V.</given-names></name><name><surname>Flamini</surname><given-names>G.</given-names></name><name><surname>Morelli</surname><given-names>I.</given-names></name><name><surname>Roccaro</surname><given-names>A.S.</given-names></name><name><surname>Alonzo</surname><given-names>V.</given-names></name></person-group><article-title>Susceptibility of methicillin-resistant staphylococci to oregano essential oil, carvacrol and thymol</article-title><source>FEMS Microbiol. Lett.</source><year>2004</year><volume>230</volume><fpage>191</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">14757239</pub-id></element-citation></ref><ref id="B15-pharmaceuticals-13-00369"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brady</surname><given-names>A.</given-names></name><name><surname>Loughlin</surname><given-names>R.</given-names></name><name><surname>Gilpin</surname><given-names>D.</given-names></name><name><surname>Kearney</surname><given-names>P.</given-names></name><name><surname>Tunney</surname><given-names>M.</given-names></name></person-group><article-title>In vitro activity of tea-tree oil against clinical skin isolates of methicillin-resistant and -sensitive <italic>Staphylococcus aureus</italic> and coagulase-negative staphylococci</article-title><source>J. Med. Microbiol.</source><year>2006</year><volume>55</volume><fpage>1375</fpage><lpage>1380</lpage><?supplied-pmid 17005786?><pub-id pub-id-type="pmid">17005786</pub-id></element-citation></ref><ref id="B16-pharmaceuticals-13-00369"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>P.</given-names></name><name><surname>Xue</surname><given-names>Y.J.</given-names></name><name><surname>Duan</surname><given-names>X.J.</given-names></name><name><surname>Shao</surname><given-names>S.H.</given-names></name></person-group><article-title>Effect of cinnamaldehyde on biofilm formation and sarA expression by methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Lett. Appl. Microbiol.</source><year>2011</year><volume>53</volume><fpage>409</fpage><lpage>416</lpage><?supplied-pmid 21767279?><pub-id pub-id-type="pmid">21767279</pub-id></element-citation></ref><ref id="B17-pharmaceuticals-13-00369"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>C&#x000e1;ceres</surname><given-names>M.</given-names></name><name><surname>Hidalgo</surname><given-names>W.</given-names></name><name><surname>Stashenko</surname><given-names>E.</given-names></name><name><surname>Torres</surname><given-names>R.</given-names></name><name><surname>Ortiz</surname><given-names>C.</given-names></name></person-group><article-title>Essential Oils of Aromatic Plants with Antibacterial, Anti-Biofilm and Anti-Quorum Sensing Activities against Pathogenic Bacteria</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><fpage>147</fpage></element-citation></ref><ref id="B18-pharmaceuticals-13-00369"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huma</surname><given-names>J.</given-names></name><name><surname>Fohad</surname><given-names>M.H.</given-names></name><name><surname>Iqbal</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial and antibiofilm activity of some Essential oils and compounds against clinical strains of <italic>Staphylococcus aureus</italic></article-title><source>J. Biomed.</source><year>2014</year><volume>1</volume><fpage>65</fpage><lpage>71</lpage></element-citation></ref><ref id="B19-pharmaceuticals-13-00369"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazzaro</surname><given-names>F.</given-names></name><name><surname>Fratianni</surname><given-names>F.</given-names></name><name><surname>de Martino</surname><given-names>L.</given-names></name><name><surname>Coppola</surname><given-names>R.</given-names></name><name><surname>de Feo</surname><given-names>V.</given-names></name></person-group><article-title>Effect of essential oils on pathogenic bacteria</article-title><source>Pharmaceuticals</source><year>2013</year><volume>6</volume><fpage>1451</fpage><lpage>1474</lpage><pub-id pub-id-type="pmid">24287491</pub-id></element-citation></ref><ref id="B20-pharmaceuticals-13-00369"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>B.K.</given-names></name><name><surname>Valdramidis</surname><given-names>V.P.</given-names></name><name><surname>O&#x02019;Donnel</surname><given-names>C.P.</given-names></name><name><surname>Muthukumarappan</surname><given-names>K.</given-names></name><name><surname>Bourke</surname><given-names>P.</given-names></name><name><surname>Cullen</surname><given-names>P.J.</given-names></name></person-group><article-title>Application of natural antimicrobials for food preservation</article-title><source>J. Food Chem.</source><year>2009</year><volume>57</volume><fpage>5987</fpage><lpage>6000</lpage></element-citation></ref><ref id="B21-pharmaceuticals-13-00369"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.J.</given-names></name><name><surname>Huang</surname><given-names>Y.C.</given-names></name></person-group><article-title>New epidemiology of <italic>Staphylococcus aureus</italic> infection in Asia</article-title><source>Clin. Microbiol. Infect.</source><year>2014</year><volume>20</volume><fpage>605</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1111/1469-0691.12705</pub-id><?supplied-pmid 24888414?><pub-id pub-id-type="pmid">24888414</pub-id></element-citation></ref><ref id="B22-pharmaceuticals-13-00369"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ippolito</surname><given-names>G.</given-names></name><name><surname>Leone</surname><given-names>S.</given-names></name><name><surname>Lauria</surname><given-names>F.N.</given-names></name><name><surname>Nicastri</surname><given-names>E.</given-names></name><name><surname>Wenzel</surname><given-names>R.P.</given-names></name></person-group><article-title>Methicillin-resistant <italic>Staphylococcus aureus</italic>: The superbug</article-title><source>Int. J. Infect. Dis.</source><year>2010</year><volume>14</volume><fpage>7</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2010.05.003</pub-id></element-citation></ref><ref id="B23-pharmaceuticals-13-00369"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sit</surname><given-names>P.S.</given-names></name><name><surname>The</surname><given-names>C.S.</given-names></name><name><surname>Idris</surname><given-names>N.</given-names></name><name><surname>Sam</surname><given-names>I.C.</given-names></name><name><surname>Syed Omar</surname><given-names>S.F.</given-names></name><name><surname>Sulaiman</surname><given-names>H.</given-names></name><name><surname>Thong</surname><given-names>K.L.</given-names></name><name><surname>Kamarulzaman</surname><given-names>A.</given-names></name><name><surname>Ponnampalavana</surname><given-names>S.</given-names></name></person-group><article-title>Prevalence of methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia</article-title><source>BMC Infect. Dis.</source><year>2017</year><volume>17</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s12879-017-2384-y</pub-id><pub-id pub-id-type="pmid">28049444</pub-id></element-citation></ref><ref id="B24-pharmaceuticals-13-00369"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sganga</surname><given-names>G.</given-names></name><name><surname>Tascini</surname><given-names>C.</given-names></name><name><surname>Sozio</surname><given-names>E.</given-names></name><name><surname>Carlini</surname><given-names>M.</given-names></name><name><surname>Chirletti</surname><given-names>P.</given-names></name><name><surname>Cortese</surname><given-names>F.</given-names></name><name><surname>Gattuso</surname><given-names>R.</given-names></name><name><surname>Granone</surname><given-names>P.</given-names></name><name><surname>Pempinello</surname><given-names>C.</given-names></name><name><surname>Sartelli</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Focus on the prophylaxis, epidemiology and therapy of methicillin-resistant <italic>Staphylococcus aureus</italic> surgical site infections and a position paper on associated risk factors: The perspective of an Italian group of surgeons</article-title><source>World J. Emerg. Surg.</source><year>2016</year><volume>11</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1186/s13017-016-0086-1</pub-id><pub-id pub-id-type="pmid">26734068</pub-id></element-citation></ref><ref id="B25-pharmaceuticals-13-00369"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akanbi</surname><given-names>B.O.</given-names></name><name><surname>Mbe</surname><given-names>J.U.</given-names></name></person-group><article-title>Occurrence of methicillin and vancomycin resistant <italic>Staphylococcus aureus</italic> in University of Abuja Teaching Hospital, Abuja, Nigeria</article-title><source>Afr. J. Clin. Exp. Microbiol.</source><year>2013</year><volume>14</volume><fpage>10</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.4314/ajcem.v14i1.3</pub-id></element-citation></ref><ref id="B26-pharmaceuticals-13-00369"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghebremedhin</surname><given-names>B.</given-names></name><name><surname>Olugbosi</surname><given-names>M.O.</given-names></name><name><surname>Raji</surname><given-names>A.M.</given-names></name><name><surname>Layer</surname><given-names>F.</given-names></name><name><surname>Bakare</surname><given-names>R.A.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>B.</given-names></name><name><surname>K&#x000f6;nig</surname><given-names>W.</given-names></name></person-group><article-title>Emergence of a community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> strain with a unique resistance profile in Southwest Nigeria</article-title><source>J. Clin. Microbiol.</source><year>2009</year><volume>47</volume><fpage>2975</fpage><lpage>2980</lpage><pub-id pub-id-type="doi">10.1128/JCM.00648-09</pub-id><pub-id pub-id-type="pmid">19571020</pub-id></element-citation></ref><ref id="B27-pharmaceuticals-13-00369"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watkins</surname><given-names>R.R.</given-names></name><name><surname>Holubar</surname><given-names>M.</given-names></name><name><surname>David</surname><given-names>M.Z.</given-names></name></person-group><article-title>Antimicrobial resistance in methicillin-resistant <italic>Staphylococcus aureus</italic> to newer antimicrobial agents</article-title><source>Antimicrob. Agents. Chemother.</source><year>2019</year><volume>63</volume><fpage>e01216-19</fpage><pub-id pub-id-type="doi">10.1128/AAC.01216-19</pub-id></element-citation></ref><ref id="B28-pharmaceuticals-13-00369"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammer</surname><given-names>K.</given-names></name><name><surname>Carson</surname><given-names>C.</given-names></name><name><surname>Riley</surname><given-names>T.</given-names></name></person-group><article-title>Antimicrobial activity of essential oils and other plant extracts</article-title><source>J. Appl. Microbiol.</source><year>1999</year><volume>86</volume><fpage>985</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.1999.00780.x</pub-id><pub-id pub-id-type="pmid">10438227</pub-id></element-citation></ref><ref id="B29-pharmaceuticals-13-00369"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pattnaik</surname><given-names>S.</given-names></name><name><surname>Subramanyam</surname><given-names>V.R.</given-names></name><name><surname>Bapaji</surname><given-names>M.</given-names></name><name><surname>Kole</surname><given-names>C.R.</given-names></name></person-group><article-title>Antibacterial and antifungal activity of aromatic constituents of essential oils</article-title><source>Microbios</source><year>1997</year><volume>89</volume><fpage>39</fpage><lpage>46</lpage><?supplied-pmid 9218354?><pub-id pub-id-type="pmid">9218354</pub-id></element-citation></ref><ref id="B30-pharmaceuticals-13-00369"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouedrhiria</surname><given-names>W.</given-names></name><name><surname>Mounyr</surname><given-names>B.</given-names></name><name><surname>Harkib</surname><given-names>H.</given-names></name><name><surname>Mojac</surname><given-names>S.</given-names></name><name><surname>Grechea</surname><given-names>H.</given-names></name></person-group><article-title>Synergistic antimicrobial activity of two binary combinations of marjoram, lavender, and wild thyme essential oils</article-title><source>Int. J. Food Prop.</source><year>2017</year><volume>12</volume><fpage>3149</fpage><lpage>3158</lpage><pub-id pub-id-type="doi">10.1080/10942912.2017.1280504</pub-id></element-citation></ref><ref id="B31-pharmaceuticals-13-00369"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>N.A.</given-names></name><name><surname>Hammer</surname><given-names>K.A.</given-names></name><name><surname>Riley</surname><given-names>T.V.</given-names></name><name><surname>Van Belkum</surname><given-names>A.</given-names></name><name><surname>Carson</surname><given-names>C.F.</given-names></name></person-group><article-title>Effect of habituation to tea tree (<italic>Melaleuca alternifolia</italic>) oil on the subsequent susceptibility of <italic>Staphylococcus</italic> spp. to antimicrobials, triclosan, tea tree oil, terpinen-4-ol and carvacrol</article-title><source>Int. J. Antimicrob. Agents</source><year>2013</year><volume>41</volume><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2012.12.011</pub-id><?supplied-pmid 23481659?><pub-id pub-id-type="pmid">23481659</pub-id></element-citation></ref><ref id="B32-pharmaceuticals-13-00369"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordeiro</surname><given-names>L.</given-names></name><name><surname>Figueiredo</surname><given-names>P.</given-names></name><name><surname>Souza</surname><given-names>H.</given-names></name><name><surname>Sousa</surname><given-names>A.</given-names></name><name><surname>Andrade-J&#x000fa;nior</surname><given-names>F.</given-names></name><name><surname>Medeiros</surname><given-names>D.</given-names></name><name><surname>N&#x000f3;brega</surname><given-names>J.</given-names></name><name><surname>Silva</surname><given-names>D.</given-names></name><name><surname>Martins</surname><given-names>E.</given-names></name><name><surname>Barbosa-Filho</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Terpinen-4-ol as an Antibacterial and Antibiofilm Agent against <italic>Staphylococcus aureus</italic></article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><elocation-id>4531</elocation-id><pub-id pub-id-type="doi">10.3390/ijms21124531</pub-id></element-citation></ref><ref id="B33-pharmaceuticals-13-00369"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leite</surname><given-names>A.M.</given-names></name><name><surname>Lima</surname><given-names>E.O.</given-names></name><name><surname>Souza</surname><given-names>E.L.</given-names></name><name><surname>Diniz</surname><given-names>M.F.F.M.</given-names></name><name><surname>Trajano</surname><given-names>V.N.</given-names></name><name><surname>Medeiros</surname><given-names>I.A.</given-names></name></person-group><article-title>Inhibitory effect of &#x003b2;-pinene, &#x003b1;-pinene and eugenol on the growth of potential infectious endocarditis causing gram-positive bacteria</article-title><source>Braz. J. Pharm. Sci.</source><year>2007</year><volume>43</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1590/S1516-93322007000100015</pub-id></element-citation></ref><ref id="B34-pharmaceuticals-13-00369"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nissen</surname><given-names>L.</given-names></name><name><surname>Zatta</surname><given-names>A.</given-names></name><name><surname>Stefanini</surname><given-names>I.</given-names></name><name><surname>Grandi</surname><given-names>S.</given-names></name><name><surname>Sgorbati</surname><given-names>B.</given-names></name><name><surname>Biavati</surname><given-names>B.</given-names></name><name><surname>Monti</surname><given-names>A.</given-names></name></person-group><article-title>Characterization and antimicrobial activity of essential oils of industrial hemp varieties (<italic>Cannabis sativa</italic> L.)</article-title><source>Fitoterapia.</source><year>2010</year><volume>81</volume><fpage>413</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2009.11.010</pub-id><pub-id pub-id-type="pmid">19969046</pub-id></element-citation></ref><ref id="B35-pharmaceuticals-13-00369"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gachkar</surname><given-names>L.</given-names></name><name><surname>Yadegari</surname><given-names>D.</given-names></name><name><surname>Rezaei</surname><given-names>M.B.</given-names></name><name><surname>Taghizadeh</surname><given-names>M.</given-names></name><name><surname>Astaneh</surname><given-names>S.A.</given-names></name><name><surname>Rasooli</surname><given-names>I.</given-names></name></person-group><article-title>Chemical and biological characteristics of <italic>Cuminum cyminum</italic> and <italic>Rosmarinus officinalis</italic> essential oils</article-title><source>Food Chem.</source><year>2007</year><volume>102</volume><fpage>898</fpage><lpage>904</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2006.06.035</pub-id></element-citation></ref><ref id="B36-pharmaceuticals-13-00369"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utegenova</surname><given-names>G.A.</given-names></name><name><surname>Pallister</surname><given-names>K.B.</given-names></name><name><surname>Kushnarenko</surname><given-names>S.V.</given-names></name><name><surname>&#x000d6;zek</surname><given-names>G.</given-names></name><name><surname>&#x000d6;zek</surname><given-names>T.</given-names></name><name><surname>Abidkulova</surname><given-names>K.T.</given-names></name><name><surname>Kirpotina</surname><given-names>L.N.</given-names></name><name><surname>Schepetkin</surname><given-names>I.A.</given-names></name><name><surname>Quinn</surname><given-names>M.T.</given-names></name><name><surname>Voyich</surname><given-names>J.M.</given-names></name></person-group><article-title>Chemical Composition and Antibacterial Activity of Essential Oils from <italic>Ferula</italic> L. Species against Methicillin-Resistant <italic>Staphylococcus aureus</italic></article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>1679</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23071679</pub-id></element-citation></ref><ref id="B37-pharmaceuticals-13-00369"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>Z.W.</given-names></name><name><surname>Yin</surname><given-names>Z.Q.</given-names></name><name><surname>Wei</surname><given-names>Q.</given-names></name><name><surname>Jia</surname><given-names>R.Y.</given-names></name><name><surname>Zhou</surname><given-names>L.J.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Du</surname><given-names>Y.H.</given-names></name><etal/></person-group><article-title>Antibacterial activity of leaf essential oil and its constituents from <italic>Cinnamomum longepaniculatum</italic></article-title><source>Int. J. Clin. Exp. Med.</source><year>2014</year><volume>7</volume><fpage>1721</fpage><lpage>1727</lpage><?supplied-pmid 25126170?><pub-id pub-id-type="pmid">25126170</pub-id></element-citation></ref><ref id="B38-pharmaceuticals-13-00369"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santoyo</surname><given-names>S.</given-names></name><name><surname>Cavero</surname><given-names>S.</given-names></name><name><surname>Jaime</surname><given-names>L.</given-names></name><name><surname>Ibanez</surname><given-names>E.</given-names></name><name><surname>Senorans</surname><given-names>F.J.</given-names></name><name><surname>Reglero</surname><given-names>G.</given-names></name></person-group><article-title>Chemical composition and antimicrobial activity of <italic>Rosmarinus officinalis</italic> L. essential oil obtained via supercritical fluidextraction</article-title><source>J. Food Protect.</source><year>2005</year><volume>68</volume><fpage>790</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.4315/0362-028X-68.4.790</pub-id><?supplied-pmid 15830672?><pub-id pub-id-type="pmid">15830672</pub-id></element-citation></ref><ref id="B39-pharmaceuticals-13-00369"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paharik</surname><given-names>A.E.</given-names></name><name><surname>Horswill</surname><given-names>A.R.</given-names></name></person-group><article-title>The Staphylococcal Bioflm: Adhesins, Regulation, and Host Response</article-title><source>Microbiol. Spectr.</source><year>2016</year><volume>4</volume><pub-id pub-id-type="doi">10.1128/microbiolspec.VMBF-0022-2015</pub-id></element-citation></ref><ref id="B40-pharmaceuticals-13-00369"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenke</surname><given-names>P.</given-names></name><name><surname>Kovacs</surname><given-names>B.</given-names></name><name><surname>Jackel</surname><given-names>M.</given-names></name><name><surname>Nagy</surname><given-names>E.</given-names></name></person-group><article-title>The role of biofilm infection in urology</article-title><source>World J. Urol.</source><year>2006</year><volume>24</volume><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1007/s00345-005-0050-2</pub-id><pub-id pub-id-type="pmid">16402262</pub-id></element-citation></ref><ref id="B41-pharmaceuticals-13-00369"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bose</surname><given-names>S.K.</given-names></name><name><surname>Chauhan</surname><given-names>M.</given-names></name><name><surname>Dhingra</surname><given-names>N.</given-names></name><name><surname>Chhibber</surname><given-names>S.</given-names></name><name><surname>Harjai</surname><given-names>K.</given-names></name></person-group><article-title>Terpinen-4-ol attenuates quorum sensing regulated virulence factors and biofilm formation in <italic>Pseudomonas aeruginosa</italic></article-title><source>Future Microbiol.</source><year>2020</year><volume>15</volume><fpage>127</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.2217/fmb-2019-0204</pub-id><pub-id pub-id-type="pmid">32043363</pub-id></element-citation></ref><ref id="B42-pharmaceuticals-13-00369"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordini</surname><given-names>E.A.F.</given-names></name><name><surname>Toron</surname><given-names>C.C.</given-names></name><name><surname>Francisconi</surname><given-names>R.S.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>F.A.C.</given-names></name><name><surname>Huacho</surname><given-names>P.M.M.</given-names></name><name><surname>Bedran</surname><given-names>T.L.</given-names></name><name><surname>Pratavieira</surname><given-names>S.</given-names></name><name><surname>Spolidorio</surname><given-names>L.C.</given-names></name><name><surname>Spolidorio</surname><given-names>D.P.</given-names></name></person-group><article-title>Antimicrobial effects of terpinen-4-ol against oral pathogens and its capacity for the modulation of gene expression</article-title><source>Biofouling</source><year>2018</year><volume>34</volume><fpage>815</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1080/08927014.2018.1504926</pub-id><?supplied-pmid 30322278?><pub-id pub-id-type="pmid">30322278</pub-id></element-citation></ref><ref id="B43-pharmaceuticals-13-00369"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maquera-Huacho</surname><given-names>P.M.</given-names></name><name><surname>Tonon</surname><given-names>C.C.</given-names></name><name><surname>Correia</surname><given-names>M.F.</given-names></name><name><surname>Francisconi</surname><given-names>R.S.</given-names></name><name><surname>Bordini</surname><given-names>E.A.F.</given-names></name><name><surname>Marcantonio</surname><given-names>&#x000c9;.</given-names></name><name><surname>Spolidorio</surname><given-names>D.M.P.</given-names></name></person-group><article-title>In vitro antibacterial and cytotoxic activities of carvacrol and terpinen-4-ol against biofilm formation on titanium implant surfaces</article-title><source>Biofouling</source><year>2018</year><volume>34</volume><fpage>699</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1080/08927014.2018.1485892</pub-id><pub-id pub-id-type="pmid">30187780</pub-id></element-citation></ref><ref id="B44-pharmaceuticals-13-00369"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nostro</surname><given-names>A.</given-names></name><name><surname>Roccaro</surname><given-names>A.S.</given-names></name><name><surname>Bisignano</surname><given-names>G.</given-names></name><name><surname>Marino</surname><given-names>A.</given-names></name><name><surname>Cannatelli</surname><given-names>M.A.</given-names></name><name><surname>Pizzimenti</surname><given-names>F.C.</given-names></name><name><surname>Cioni</surname><given-names>P.L.</given-names></name><name><surname>Procopio</surname><given-names>F.</given-names></name><name><surname>Blanco</surname><given-names>A.R.</given-names></name></person-group><article-title>Effects of oregano, carvacrol and thymol on <italic>Staphylococcus aureus</italic> and <italic>Staphylococcus epidermidis</italic> biofilms</article-title><source>J. Med. Microbiol.</source><year>2007</year><volume>56</volume><fpage>519</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.46804-0</pub-id><pub-id pub-id-type="pmid">17374894</pub-id></element-citation></ref><ref id="B45-pharmaceuticals-13-00369"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpanen</surname><given-names>T.J.</given-names></name><name><surname>Worthington</surname><given-names>T.</given-names></name><name><surname>Hendry</surname><given-names>E.R.</given-names></name><name><surname>Conway</surname><given-names>B.R.</given-names></name><name><surname>Lambert</surname><given-names>P.A.</given-names></name></person-group><article-title>Antimicrobial efficacy of chlorhexidine digluconate alone and in combination with eucalyptus oil, tea tree oil and thymol against planktonic and biofilm cultures of <italic>Staphylococcus epidermidis</italic></article-title><source>J. Antimicrob. Chemother.</source><year>2008</year><volume>62</volume><fpage>1031</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1093/jac/dkn325</pub-id><pub-id pub-id-type="pmid">18703525</pub-id></element-citation></ref><ref id="B46-pharmaceuticals-13-00369"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hendry</surname><given-names>E.R.</given-names></name><name><surname>Worthington</surname><given-names>T.</given-names></name><name><surname>Conway</surname><given-names>B.R.</given-names></name><name><surname>Lambert</surname><given-names>P.A.</given-names></name></person-group><article-title>Antimicrobial efficacy of eucalyptus oil and 1,8-cineole alone and in combination with chlorhexidine digluconate against microorganisms grown in planktonic and biofilm cultures</article-title><source>J. Antimicrob. Chemother.</source><year>2009</year><volume>64</volume><fpage>1219</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1093/jac/dkp362</pub-id><pub-id pub-id-type="pmid">19837714</pub-id></element-citation></ref><ref id="B47-pharmaceuticals-13-00369"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuryastuti</surname><given-names>T.</given-names></name><name><surname>van der Mei</surname><given-names>H.C.</given-names></name><name><surname>Busscher</surname><given-names>H.J.</given-names></name><name><surname>Iravati</surname><given-names>S.</given-names></name><name><surname>Aman</surname><given-names>A.T.</given-names></name><name><surname>Krom</surname><given-names>B.P.</given-names></name></person-group><article-title>Effect of cinnamon oil on <italic>icaA</italic> expression and biofilm formation by <italic>Staphylococcus epidermidis</italic></article-title><source>Appl. Environ. Microbiol.</source><year>2009</year><volume>75</volume><fpage>6850</fpage><lpage>6855</lpage><pub-id pub-id-type="doi">10.1128/AEM.00875-09</pub-id><pub-id pub-id-type="pmid">19749058</pub-id></element-citation></ref><ref id="B48-pharmaceuticals-13-00369"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceylan</surname><given-names>O.</given-names></name><name><surname>U&#x0011f;ur</surname><given-names>A.</given-names></name><name><surname>Sara&#x000e7;</surname><given-names>N.</given-names></name><name><surname>Ozcan</surname><given-names>F.</given-names></name><name><surname>Baygar</surname><given-names>T.</given-names></name></person-group><article-title>The in vitro antibiofilm activity of <italic>Rosmarinus officinalis</italic> L. essential oil against multiple antibiotic resistant <italic>Pseudomonas</italic> sp. and <italic>Staphylococcus</italic> sp.</article-title><source>J. Food Agric. Environ.</source><year>2014</year><volume>12</volume><fpage>82</fpage><lpage>86</lpage></element-citation></ref><ref id="B49-pharmaceuticals-13-00369"><label>49.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>P.</given-names></name><name><surname>Jorgenson</surname><given-names>J.H.</given-names></name><name><surname>Pfaller</surname><given-names>M.A.M.</given-names></name><name><surname>Yolken</surname><given-names>R.H.</given-names></name></person-group><source>Manual of Clinical Microbiology</source><edition>8th ed.</edition><publisher-name>ASM Press</publisher-name><publisher-loc>Washington, DC, USA</publisher-loc><year>2003</year></element-citation></ref><ref id="B50-pharmaceuticals-13-00369"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>J.M.</given-names></name><name><surname>Howe</surname><given-names>R.A.</given-names></name></person-group><article-title>BSAC standardized disc susceptibility testing method (version 10)</article-title><source>J. Antimicrob. Chemother.</source><year>2011</year><volume>66</volume><fpage>2726</fpage><lpage>2757</lpage><pub-id pub-id-type="doi">10.1093/jac/dkr359</pub-id><pub-id pub-id-type="pmid">21921076</pub-id></element-citation></ref><ref id="B51-pharmaceuticals-13-00369"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goor&#x000e9;a</surname><given-names>S.G.</given-names></name><name><surname>Ouattara</surname><given-names>Z.A.</given-names></name><name><surname>Yapi</surname><given-names>A.T.</given-names></name><name><surname>B&#x000e9;kro</surname><given-names>Y.A.</given-names></name><name><surname>Bighelli</surname><given-names>A.</given-names></name><name><surname>Paoli</surname><given-names>M.</given-names></name><name><surname>Tomi</surname><given-names>F.</given-names></name></person-group><article-title>Chemical composition of the leaf oil of <italic>Artabotrys jollyanus</italic> from C&#x000f4;te d&#x02019;Ivoire</article-title><source>Rev. Bras. Farmacogn.</source><year>2017</year><volume>27</volume><fpage>414</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2017.04.001</pub-id></element-citation></ref><ref id="B52-pharmaceuticals-13-00369"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagamboula</surname><given-names>C.</given-names></name><name><surname>Uyttendaele</surname><given-names>M.</given-names></name><name><surname>Debevere</surname><given-names>J.</given-names></name></person-group><article-title>Inhibitory effect of thyme and basil essential oils, carvacrol, thymol, estragol, linalool and p-cymene towards <italic>Shigella sonnei</italic> and <italic>S. flexneri</italic></article-title><source>J. Food microbiol.</source><year>2004</year><volume>21</volume><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/S0740-0020(03)00046-7</pub-id></element-citation></ref><ref id="B53-pharmaceuticals-13-00369"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Deeb</surname><given-names>B.</given-names></name><name><surname>Elhariry</surname><given-names>H.</given-names></name><name><surname>Mostafa</surname><given-names>N.Y.</given-names></name></person-group><article-title>Antimicrobial Activity of Silver and Gold Nanoparticles Biosynthesized Using Ginger Extract</article-title><source>Res. J. Pharm. Biol. Chem. Sci.</source><year>2016</year><volume>7</volume><fpage>1085</fpage></element-citation></ref><ref id="B54-pharmaceuticals-13-00369"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulluce</surname><given-names>M.</given-names></name><name><surname>Sahin</surname><given-names>F.</given-names></name><name><surname>Sokmen</surname><given-names>M.</given-names></name></person-group><article-title>Antimicrobial and antioxidant properties of the essential oils and methanol extract from <italic>Mentha longifolia</italic> L.</article-title><source>Food Chem.</source><year>2007</year><volume>103</volume><fpage>1449</fpage><lpage>1456</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2006.10.061</pub-id></element-citation></ref><ref id="B55-pharmaceuticals-13-00369"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oulkheir</surname><given-names>S.</given-names></name><name><surname>Aghrouch</surname><given-names>M.</given-names></name><name><surname>El Mourabit</surname><given-names>F.</given-names></name><name><surname>Dalha</surname><given-names>F.</given-names></name><name><surname>Graich</surname><given-names>H.</given-names></name><name><surname>Amouch</surname><given-names>F.</given-names></name><name><surname>Ouzaid</surname><given-names>K.</given-names></name><name><surname>Moukale</surname><given-names>A.</given-names></name><name><surname>Chadli</surname><given-names>S.</given-names></name></person-group><article-title>Antibacterial Activity of Essential Oils Extracts from Cinnamon, Thyme, Clove and Geranium against a Gram Negative and Gram-Positive Pathogenic Bacteria</article-title><source>J. Dis. Med. Plants</source><year>2017</year><volume>3</volume><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="B56-pharmaceuticals-13-00369"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben Abdallah</surname><given-names>F.</given-names></name><name><surname>Chaieb</surname><given-names>K.</given-names></name><name><surname>Zmantar</surname><given-names>T.</given-names></name><name><surname>Kallel</surname><given-names>H.</given-names></name><name><surname>Bakhrouf</surname><given-names>A.</given-names></name></person-group><article-title>Adherence assays and Slime production of <italic>Vibrio alginolyticus</italic> and <italic>Vibrio parahaemolyticus</italic></article-title><source>Braz. J. Microbiol.</source><year>2009</year><volume>40</volume><fpage>394</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.1590/S1517-83822009000200033</pub-id><?supplied-pmid 24031378?><pub-id pub-id-type="pmid">24031378</pub-id></element-citation></ref><ref id="B57-pharmaceuticals-13-00369"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jadhav</surname><given-names>S.</given-names></name><name><surname>Shah</surname><given-names>R.</given-names></name><name><surname>Bhave</surname><given-names>M.</given-names></name><name><surname>Palombo</surname><given-names>E.A.</given-names></name></person-group><article-title>Inhibitory activity of yarrow essential oil on <italic>Listeria</italic> planktonic cells and biofilms</article-title><source>J. Food Control</source><year>2013</year><volume>29</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/j.foodcont.2012.05.071</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="pharmaceuticals-13-00369-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Distribution of MRSA isolates.</p></caption><graphic xlink:href="pharmaceuticals-13-00369-g001"/></fig><table-wrap id="pharmaceuticals-13-00369-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00369-t001_Table 1</object-id><label>Table 1</label><caption><p>Chemical composition of the essential oils.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Components</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>O. majorana</italic> (%) [<xref rid="B13-pharmaceuticals-13-00369" ref-type="bibr">13</xref>]</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>T. zygis</italic> (%) [<xref rid="B13-pharmaceuticals-13-00369" ref-type="bibr">13</xref>]</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>R. officinalis</italic> (%)</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Pinene</td><td align="left" valign="middle" rowspan="1" colspan="1">0.46</td><td align="left" valign="middle" rowspan="1" colspan="1">3.6</td><td align="left" valign="middle" rowspan="1" colspan="1">37.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sabinene</td><td align="left" valign="middle" rowspan="1" colspan="1">8</td><td align="left" valign="middle" rowspan="1" colspan="1">0.84</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Pinene</td><td align="left" valign="middle" rowspan="1" colspan="1">1.4</td><td align="left" valign="middle" rowspan="1" colspan="1">0.33</td><td align="left" valign="middle" rowspan="1" colspan="1">1.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Myrcene</td><td align="left" valign="middle" rowspan="1" colspan="1">1.1</td><td align="left" valign="middle" rowspan="1" colspan="1">8.6</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-phellandrene</td><td align="left" valign="middle" rowspan="1" colspan="1">0.30</td><td align="left" valign="middle" rowspan="1" colspan="1">0.48</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Limonene</td><td align="left" valign="middle" rowspan="1" colspan="1">3.5</td><td align="left" valign="middle" rowspan="1" colspan="1">2.6</td><td align="left" valign="middle" rowspan="1" colspan="1">4.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Terpinen-4-ol</td><td align="left" valign="middle" rowspan="1" colspan="1">25.9</td><td align="left" valign="middle" rowspan="1" colspan="1">11.7</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bornyl acetate</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">0.07</td><td align="left" valign="middle" rowspan="1" colspan="1">9.1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b2;-Caryophyllene</td><td align="left" valign="middle" rowspan="1" colspan="1">2.3</td><td align="left" valign="middle" rowspan="1" colspan="1">1.6</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Thujene </td><td align="left" valign="middle" rowspan="1" colspan="1">0.33</td><td align="left" valign="middle" rowspan="1" colspan="1">0.21</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Camphene </td><td align="left" valign="middle" rowspan="1" colspan="1">0.03</td><td align="left" valign="middle" rowspan="1" colspan="1">0.74</td><td align="left" valign="middle" rowspan="1" colspan="1">7.3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Terpinene</td><td align="left" valign="middle" rowspan="1" colspan="1">7.7</td><td align="left" valign="middle" rowspan="1" colspan="1">4.2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>p</italic>-Cymene</td><td align="left" valign="middle" rowspan="1" colspan="1">3.4</td><td align="left" valign="middle" rowspan="1" colspan="1">2.2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">1,8-Cineole</td><td align="left" valign="middle" rowspan="1" colspan="1">0.15</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">4.7</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b3;-Terpinene</td><td align="left" valign="middle" rowspan="1" colspan="1">16.9</td><td align="left" valign="middle" rowspan="1" colspan="1">7.6</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Terpinolene</td><td align="left" valign="middle" rowspan="1" colspan="1">1.7</td><td align="left" valign="middle" rowspan="1" colspan="1">2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Linalool</td><td align="left" valign="middle" rowspan="1" colspan="1">10.9</td><td align="left" valign="middle" rowspan="1" colspan="1">39.7</td><td align="left" valign="middle" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Borneol</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">1.9</td><td align="left" valign="middle" rowspan="1" colspan="1">5.5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Terpineol</td><td align="left" valign="middle" rowspan="1" colspan="1">2.5</td><td align="left" valign="middle" rowspan="1" colspan="1">1.7</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Camphor</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">0.22</td><td align="left" valign="middle" rowspan="1" colspan="1">5.2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x003b1;-Humulene</td><td align="left" valign="middle" rowspan="1" colspan="1">0.05</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>cis</italic> and <italic>trans</italic>-thujan-4-ol</td><td align="left" valign="middle" rowspan="1" colspan="1">2.2&#x02013;2.3</td><td align="left" valign="middle" rowspan="1" colspan="1">0.88&#x02013;2.2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>cis</italic> and <italic>trans</italic> piperitol</td><td align="left" valign="middle" rowspan="1" colspan="1">0.13&#x02013;0.18</td><td align="left" valign="middle" rowspan="1" colspan="1">0.13&#x02013;0.08</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Linalyl acetate</td><td align="left" valign="middle" rowspan="1" colspan="1">7</td><td align="left" valign="middle" rowspan="1" colspan="1">0.5</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Carvacrol</td><td align="left" valign="middle" rowspan="1" colspan="1">0.03</td><td align="left" valign="middle" rowspan="1" colspan="1">0.08</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Thymol</td><td align="left" valign="middle" rowspan="1" colspan="1">0.05</td><td align="left" valign="middle" rowspan="1" colspan="1">0.52</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bicyclogermacrene</td><td align="left" valign="middle" rowspan="1" colspan="1">0.41</td><td align="left" valign="middle" rowspan="1" colspan="1">0.16</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Cis</italic> and <italic>trans</italic>-p-menth-2-en-1-ol</td><td align="left" valign="middle" rowspan="1" colspan="1">0.59&#x02013;0.32</td><td align="left" valign="middle" rowspan="1" colspan="1">0.37&#x02013;0.25</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Caryophyllene oxide</td><td align="left" valign="middle" rowspan="1" colspan="1">0.04</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ocimene</td><td align="left" valign="middle" rowspan="1" colspan="1">0.07</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Spathulenol</td><td align="left" valign="middle" rowspan="1" colspan="1">0.01</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>cis</italic>-Dihydrocarvone </td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">0.17</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">trans-Dihydrocarvone</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">0.2</td><td align="left" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Verbenone</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.4</td></tr></tbody></table></table-wrap><table-wrap id="pharmaceuticals-13-00369-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00369-t002_Table 2</object-id><label>Table 2</label><caption><p>Antimicrobial effect of EOs against MRSA isolates using disc diffusion.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Essential Oils</th><th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Inhibitory Action</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Strong <italic>n</italic> (%)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Complete <italic>n</italic> (%)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Partial <italic>n</italic> (%)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Slight <italic>n</italic> (%)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No Action <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>O. majorana</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">16 (53.33%)</td><td align="center" valign="middle" rowspan="1" colspan="1">11 (36.66%)</td><td align="center" valign="middle" rowspan="1" colspan="1">3 (10%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<italic>T. zygis</italic>
</td><td align="center" valign="middle" rowspan="1" colspan="1">24 (80%)</td><td align="center" valign="middle" rowspan="1" colspan="1">6 (20%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>R. officinalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (16.66%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (16.66%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (20%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 (46.66%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p><italic>n</italic>: number of isolates.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00369-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00369-t003_Table 3</object-id><label>Table 3</label><caption><p>Biofilm formation ability of MRSA isolates on polystyrene surface.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Isolates</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Specimen</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biofilm Formation</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">Burn</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">Blood</td><td align="center" valign="middle" rowspan="1" colspan="1">2.609 &#x000b1; 0.088</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">3.635 &#x000b1; 0.052</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">1.437 &#x000b1; 0.074</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">1.175 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">SSI</td><td align="center" valign="middle" rowspan="1" colspan="1">0.147 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">0.135 &#x000b1; 0.031</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">Burn</td><td align="center" valign="middle" rowspan="1" colspan="1">1.971 &#x000b1; 0.049</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 &#x000b1; 0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">1.378 &#x000b1; 0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">0.194 &#x000b1; 0.075</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">1.554 &#x000b1; 0.086</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">0.305 &#x000b1; 0.021</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">2.157 &#x000b1; 0.071</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">0.045 &#x000b1; 0.007</td><td align="center" valign="middle" rowspan="1" colspan="1">Negative</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">0.198 &#x000b1; 0.078</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">SSI</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87 &#x000b1; 0.023</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">0.221 &#x000b1; 0.048</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">Burn</td><td align="center" valign="middle" rowspan="1" colspan="1">0.428 &#x000b1; 0.068</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">0.745 &#x000b1; 0.018</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">Nasal</td><td align="center" valign="middle" rowspan="1" colspan="1">0.319 &#x000b1; 0.012</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">0.233 &#x000b1; 0.087</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">0.788 &#x000b1; 0.027</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">SSI</td><td align="center" valign="middle" rowspan="1" colspan="1">0.642 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">1.836 &#x000b1; 0.038</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">Burn</td><td align="center" valign="middle" rowspan="1" colspan="1">2.696 &#x000b1; 0.054</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">0.418 &#x000b1; 0.056</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">Burn</td><td align="center" valign="middle" rowspan="1" colspan="1">0.438 &#x000b1; 0.067</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">SSI</td><td align="center" valign="middle" rowspan="1" colspan="1">0.113 &#x000b1; 0.045</td><td align="center" valign="middle" rowspan="1" colspan="1">low-grade positive</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">SST</td><td align="center" valign="middle" rowspan="1" colspan="1">2.308 &#x000b1; 0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">highly positive</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 25923</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.36 &#x000b1; 0.098</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">highly positive</td></tr></tbody></table><table-wrap-foot><fn><p>SST: skin and soft tissue; SSI: surgical site infection.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00369-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00369-t004_Table 4</object-id><label>Table 4</label><caption><p>Biofilm inhibition activity of EOs against MRSA isolates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Isolates</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>O. majorana</italic> OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inhibition (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>T. zygis</italic> OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inhibition (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>R. officinalis</italic> OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inhibition (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0.061 &#x000b1; 0.004 *</td><td align="center" valign="middle" rowspan="1" colspan="1">74.58</td><td align="center" valign="middle" rowspan="1" colspan="1">0.112 &#x000b1; 0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">53.33</td><td align="center" valign="middle" rowspan="1" colspan="1">0.238 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2.609 &#x000b1; 0.088</td><td align="center" valign="middle" rowspan="1" colspan="1">2.603 &#x000b1; 0.093</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">2.61 &#x000b1; 0.019</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">2.595 &#x000b1; 0.098</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">3.635 &#x000b1; 0.052</td><td align="center" valign="middle" rowspan="1" colspan="1">2.701 &#x000b1; 0.082</td><td align="center" valign="middle" rowspan="1" colspan="1">25.69</td><td align="center" valign="middle" rowspan="1" colspan="1">3.658 &#x000b1; 0.01</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">2.744 &#x000b1; 0.066</td><td align="center" valign="middle" rowspan="1" colspan="1">24.51</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">1.437 &#x000b1; 0.074</td><td align="center" valign="middle" rowspan="1" colspan="1">0.131 &#x000b1; 0.038 **</td><td align="center" valign="middle" rowspan="1" colspan="1">90.88</td><td align="center" valign="middle" rowspan="1" colspan="1">0.965 &#x000b1; 0.022 **</td><td align="center" valign="middle" rowspan="1" colspan="1">32.84</td><td align="center" valign="middle" rowspan="1" colspan="1">0.728 &#x000b1; 0.084 **</td><td align="center" valign="middle" rowspan="1" colspan="1">49.33</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.175 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">0.048 &#x000b1; 0.006 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">95.91</td><td align="center" valign="middle" rowspan="1" colspan="1">0.1 &#x000b1; 0.038 **</td><td align="center" valign="middle" rowspan="1" colspan="1">91.48</td><td align="center" valign="middle" rowspan="1" colspan="1">0.051 &#x000b1; 0.004 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">95.65</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.147 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03 &#x000b1; 0.008 *</td><td align="center" valign="middle" rowspan="1" colspan="1">79.59</td><td align="center" valign="middle" rowspan="1" colspan="1">0.124 &#x000b1; 0.043</td><td align="center" valign="middle" rowspan="1" colspan="1">15.64</td><td align="center" valign="middle" rowspan="1" colspan="1">0.132 &#x000b1; 0.023</td><td align="center" valign="middle" rowspan="1" colspan="1">10.20</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.135 &#x000b1; 0.031</td><td align="center" valign="middle" rowspan="1" colspan="1">0.114 &#x000b1; 0.023</td><td align="center" valign="middle" rowspan="1" colspan="1">15.55</td><td align="center" valign="middle" rowspan="1" colspan="1">0.136 &#x000b1; 0.073</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.134 &#x000b1; 0.011</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">1.971 &#x000b1; 0.049</td><td align="center" valign="middle" rowspan="1" colspan="1">0.105 &#x000b1; 0.018 **</td><td align="center" valign="middle" rowspan="1" colspan="1">94.67</td><td align="center" valign="middle" rowspan="1" colspan="1">0.239 &#x000b1; 0.088 **</td><td align="center" valign="middle" rowspan="1" colspan="1">87.87</td><td align="center" valign="middle" rowspan="1" colspan="1">0.346 &#x000b1; 0.018 **</td><td align="center" valign="middle" rowspan="1" colspan="1">82.44</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19 &#x000b1; 0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">0.049 &#x000b1; 0.009 *</td><td align="center" valign="middle" rowspan="1" colspan="1">74.21</td><td align="center" valign="middle" rowspan="1" colspan="1">0.138 &#x000b1; 0.043</td><td align="center" valign="middle" rowspan="1" colspan="1">27.36</td><td align="center" valign="middle" rowspan="1" colspan="1">0.146 &#x000b1; 0.093</td><td align="center" valign="middle" rowspan="1" colspan="1">23.15</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.378 &#x000b1; 0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">1.387 &#x000b1; 0.038</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.369 &#x000b1; 0.054</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.828 &#x000b1; 0.082 **</td><td align="center" valign="middle" rowspan="1" colspan="1">39.91</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.194 &#x000b1; 0.075</td><td align="center" valign="middle" rowspan="1" colspan="1">0.02 &#x000b1; 0.005 *</td><td align="center" valign="middle" rowspan="1" colspan="1">89.69</td><td align="center" valign="middle" rowspan="1" colspan="1">0.142 &#x000b1; 0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">26.80</td><td align="center" valign="middle" rowspan="1" colspan="1">0.111 &#x000b1; 0.044</td><td align="center" valign="middle" rowspan="1" colspan="1">42.78</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">1.554 &#x000b1; 0.086</td><td align="center" valign="middle" rowspan="1" colspan="1">0.162 &#x000b1; 0.077 **</td><td align="center" valign="middle" rowspan="1" colspan="1">89.57</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22 &#x000b1; 0.077 **</td><td align="center" valign="middle" rowspan="1" colspan="1">85.84</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17 &#x000b1; 0.023 **</td><td align="center" valign="middle" rowspan="1" colspan="1">89.06</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.305 &#x000b1; 0.021</td><td align="center" valign="middle" rowspan="1" colspan="1">0.027 &#x000b1; 0.006 *</td><td align="center" valign="middle" rowspan="1" colspan="1">91.14</td><td align="center" valign="middle" rowspan="1" colspan="1">0.303 &#x000b1; 0.032</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.301 &#x000b1; 0.069</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">2.157 &#x000b1; 0.071</td><td align="center" valign="middle" rowspan="1" colspan="1">1.935 &#x000b1; 0.014</td><td align="center" valign="middle" rowspan="1" colspan="1">10.29</td><td align="center" valign="middle" rowspan="1" colspan="1">2.154 &#x000b1; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.724 &#x000b1; 0.092</td><td align="center" valign="middle" rowspan="1" colspan="1">20.07</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.198 &#x000b1; 0.078</td><td align="center" valign="middle" rowspan="1" colspan="1">0.038 &#x000b1; 0.009 *</td><td align="center" valign="middle" rowspan="1" colspan="1">80.80</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072 &#x000b1; 0.008 *</td><td align="center" valign="middle" rowspan="1" colspan="1">63.63</td><td align="center" valign="middle" rowspan="1" colspan="1">0.053 &#x000b1; 0.006 *</td><td align="center" valign="middle" rowspan="1" colspan="1">73.23</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.87 &#x000b1; 0.023</td><td align="center" valign="middle" rowspan="1" colspan="1">0.043 &#x000b1; 0.017 *</td><td align="center" valign="middle" rowspan="1" colspan="1">95.05</td><td align="center" valign="middle" rowspan="1" colspan="1">0.124 &#x000b1; 0.089</td><td align="center" valign="middle" rowspan="1" colspan="1">85.74</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">81.60</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">0.221 &#x000b1; 0.048</td><td align="center" valign="middle" rowspan="1" colspan="1">0.105 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">52.48</td><td align="center" valign="middle" rowspan="1" colspan="1">0.142 &#x000b1; 0.037</td><td align="center" valign="middle" rowspan="1" colspan="1">35.74</td><td align="center" valign="middle" rowspan="1" colspan="1">0.122 &#x000b1; 0.038</td><td align="center" valign="middle" rowspan="1" colspan="1">44.79</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.428 &#x000b1; 0.068</td><td align="center" valign="middle" rowspan="1" colspan="1">0.053 &#x000b1; 0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">87.61</td><td align="center" valign="middle" rowspan="1" colspan="1">0.095 &#x000b1; 0.002 *</td><td align="center" valign="middle" rowspan="1" colspan="1">77.80</td><td align="center" valign="middle" rowspan="1" colspan="1">0.226 &#x000b1; 0.077</td><td align="center" valign="middle" rowspan="1" colspan="1">47.19</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">0.745 &#x000b1; 0.018</td><td align="center" valign="middle" rowspan="1" colspan="1">0.055 &#x000b1; 0.033 *</td><td align="center" valign="middle" rowspan="1" colspan="1">92.61</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11 &#x000b1; 0.082</td><td align="center" valign="middle" rowspan="1" colspan="1">85.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.562 &#x000b1; 0.065</td><td align="center" valign="middle" rowspan="1" colspan="1">24.56</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">0.319 &#x000b1; 0.012</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072 &#x000b1; 0.013 *</td><td align="center" valign="middle" rowspan="1" colspan="1">77.42</td><td align="center" valign="middle" rowspan="1" colspan="1">0.317 &#x000b1; 0.075</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.085 &#x000b1; 0.004 *</td><td align="center" valign="middle" rowspan="1" colspan="1">73.35</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.233 &#x000b1; 0.087</td><td align="center" valign="middle" rowspan="1" colspan="1">0.231 &#x000b1; 0.032</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.131 &#x000b1; 0.012</td><td align="center" valign="middle" rowspan="1" colspan="1">43.77</td><td align="center" valign="middle" rowspan="1" colspan="1">0.089 &#x000b1; 0.003 *</td><td align="center" valign="middle" rowspan="1" colspan="1">61.80</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.788 &#x000b1; 0.027</td><td align="center" valign="middle" rowspan="1" colspan="1">0.554 &#x000b1; 0.065</td><td align="center" valign="middle" rowspan="1" colspan="1">29.69</td><td align="center" valign="middle" rowspan="1" colspan="1">0.696 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">11.67</td><td align="center" valign="middle" rowspan="1" colspan="1">0.465 &#x000b1; 0.073</td><td align="center" valign="middle" rowspan="1" colspan="1">40.98</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">0.642 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">0.192 &#x000b1; 0.013</td><td align="center" valign="middle" rowspan="1" colspan="1">70.09</td><td align="center" valign="middle" rowspan="1" colspan="1">0.639 &#x000b1; 0.087</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.241 &#x000b1; 0.053</td><td align="center" valign="middle" rowspan="1" colspan="1">62.461</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">1.836 &#x000b1; 0.038</td><td align="center" valign="middle" rowspan="1" colspan="1">1.325 &#x000b1; 0.078</td><td align="center" valign="middle" rowspan="1" colspan="1">27.83</td><td align="center" valign="middle" rowspan="1" colspan="1">1.84 &#x000b1; 0.042</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.821 &#x000b1; 0.096</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">2.696 &#x000b1; 0.054</td><td align="center" valign="middle" rowspan="1" colspan="1">2.196 &#x000b1; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">18.54</td><td align="center" valign="middle" rowspan="1" colspan="1">2.206 &#x000b1; 0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">18.17</td><td align="center" valign="middle" rowspan="1" colspan="1">2.012 &#x000b1; 0.014</td><td align="center" valign="middle" rowspan="1" colspan="1">25.37</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">0.418 &#x000b1; 0.056</td><td align="center" valign="middle" rowspan="1" colspan="1">0.254 &#x000b1; 0.068</td><td align="center" valign="middle" rowspan="1" colspan="1">39.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.415 &#x000b1; 0.069</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.065 &#x000b1; 0.008 *</td><td align="center" valign="middle" rowspan="1" colspan="1">84.44</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">0.438 &#x000b1; 0.067</td><td align="center" valign="middle" rowspan="1" colspan="1">0.034 &#x000b1; 0.005 *</td><td align="center" valign="middle" rowspan="1" colspan="1">92.23</td><td align="center" valign="middle" rowspan="1" colspan="1">0.217 &#x000b1; 0.016</td><td align="center" valign="middle" rowspan="1" colspan="1">50.45</td><td align="center" valign="middle" rowspan="1" colspan="1">0.069 &#x000b1; 0.002 *</td><td align="center" valign="middle" rowspan="1" colspan="1">84.24</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">0.113 &#x000b1; 0.045</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11 &#x000b1; 0.022</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.016 &#x000b1; 0.006 *</td><td align="center" valign="middle" rowspan="1" colspan="1">85.84</td><td align="center" valign="middle" rowspan="1" colspan="1">0.114 &#x000b1; 0.032</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">2.308 &#x000b1; 0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">1.533 &#x000b1; 0.055</td><td align="center" valign="middle" rowspan="1" colspan="1">33.57</td><td align="center" valign="middle" rowspan="1" colspan="1">2.306 &#x000b1; 0.086</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.907 &#x000b1; 0.048 **</td><td align="center" valign="middle" rowspan="1" colspan="1">60.70</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 25922</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.36 &#x000b1; 0.098</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.838 &#x000b1; 0.066</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45.29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.352 &#x000b1; 0.014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.345 &#x000b1; 0.029</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn><p>* Isolates changed from low-grade positive to biofilm negative after treatment with EOs. ** Isolates changed from highly positive to low-grade positive after treatment with EOs. *** Isolates changed from highly positive to biofilm negative after treatment with EOs.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pharmaceuticals-13-00369-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">pharmaceuticals-13-00369-t005_Table 5</object-id><label>Table 5</label><caption><p>Biofilm eradication activity of EOs against MRSA isolates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Isolates</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>O. majorana</italic> OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Eradication (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>T. zygis</italic> OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Eradication (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>R. officinalis</italic> OD570 &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Eradication (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.418 &#x000b1; 0.024</td><td align="center" valign="middle" rowspan="1" colspan="1">0.417 &#x000b1; 0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.415 &#x000b1; 0.019</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.413 &#x000b1; 0.021</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">3.13 &#x000b1; 0.096</td><td align="center" valign="middle" rowspan="1" colspan="1">1.754 &#x000b1; 0.055</td><td align="center" valign="middle" rowspan="1" colspan="1">43.96</td><td align="center" valign="middle" rowspan="1" colspan="1">1.626 &#x000b1; 0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">48.05</td><td align="center" valign="middle" rowspan="1" colspan="1">2.709 &#x000b1; 0.084</td><td align="center" valign="middle" rowspan="1" colspan="1">13.45</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">4.362 &#x000b1; 0.086</td><td align="center" valign="middle" rowspan="1" colspan="1">2.92 &#x000b1; 0.071</td><td align="center" valign="middle" rowspan="1" colspan="1">33.05</td><td align="center" valign="middle" rowspan="1" colspan="1">3.468 &#x000b1; 0.091</td><td align="center" valign="middle" rowspan="1" colspan="1">20.49</td><td align="center" valign="middle" rowspan="1" colspan="1">2.15 &#x000b1; 0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">50.71</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">1.939 &#x000b1; 0.078</td><td align="center" valign="middle" rowspan="1" colspan="1">1.941 &#x000b1; 0.069</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.931 &#x000b1; 0.074</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.115 &#x000b1; 0.063</td><td align="center" valign="middle" rowspan="1" colspan="1">42.49</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">1.41 &#x000b1; 0.088</td><td align="center" valign="middle" rowspan="1" colspan="1">0.237 &#x000b1; 0.025 **</td><td align="center" valign="middle" rowspan="1" colspan="1">83.19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.079 &#x000b1; 0.008 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">94.39</td><td align="center" valign="middle" rowspan="1" colspan="1">0.103 &#x000b1; 0.011 **</td><td align="center" valign="middle" rowspan="1" colspan="1">92.69</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">0.176 &#x000b1; 0.016</td><td align="center" valign="middle" rowspan="1" colspan="1">0.078 &#x000b1; 0.005 *</td><td align="center" valign="middle" rowspan="1" colspan="1">55.68</td><td align="center" valign="middle" rowspan="1" colspan="1">0.061 &#x000b1; 0.004 *</td><td align="center" valign="middle" rowspan="1" colspan="1">65.34</td><td align="center" valign="middle" rowspan="1" colspan="1">0.131 &#x000b1; 0.018</td><td align="center" valign="middle" rowspan="1" colspan="1">25.56</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.189 &#x000b1; 0.012</td><td align="center" valign="middle" rowspan="1" colspan="1">0.185 &#x000b1; 0.013</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.191 &#x000b1; 0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.186 &#x000b1; 0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">2.465 &#x000b1; 0.083</td><td align="center" valign="middle" rowspan="1" colspan="1">0.37 &#x000b1; 0.045 **</td><td align="center" valign="middle" rowspan="1" colspan="1">84.98</td><td align="center" valign="middle" rowspan="1" colspan="1">2.153 &#x000b1; 0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">12.65</td><td align="center" valign="middle" rowspan="1" colspan="1">1.143 &#x000b1; 0.059</td><td align="center" valign="middle" rowspan="1" colspan="1">53.63</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9</td><td align="center" valign="middle" rowspan="1" colspan="1">0.304 &#x000b1; 0.056</td><td align="center" valign="middle" rowspan="1" colspan="1">0.308 &#x000b1; 0.021</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.309 &#x000b1; 0.022</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.302 &#x000b1; 0.024</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.722 &#x000b1; 0.066</td><td align="center" valign="middle" rowspan="1" colspan="1">0.386 &#x000b1; 0.027 **</td><td align="center" valign="middle" rowspan="1" colspan="1">77.58</td><td align="center" valign="middle" rowspan="1" colspan="1">1.074 &#x000b1; 0.055</td><td align="center" valign="middle" rowspan="1" colspan="1">37.63</td><td align="center" valign="middle" rowspan="1" colspan="1">0.174 &#x000b1; 0.014 **</td><td align="center" valign="middle" rowspan="1" colspan="1">89.89</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.269 &#x000b1; 0.013</td><td align="center" valign="middle" rowspan="1" colspan="1">0.262 &#x000b1; 0.016</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.265 &#x000b1; 0.025</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.271 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">2.334 &#x000b1; 0.073</td><td align="center" valign="middle" rowspan="1" colspan="1">0.687 &#x000b1; 0.032 **</td><td align="center" valign="middle" rowspan="1" colspan="1">70.56</td><td align="center" valign="middle" rowspan="1" colspan="1">1.356 &#x000b1; 0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">41.90</td><td align="center" valign="middle" rowspan="1" colspan="1">2.328 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.433 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0.431 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.436 &#x000b1; 0.031</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43 &#x000b1; 0.032</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">2.617 &#x000b1; 0.078</td><td align="center" valign="middle" rowspan="1" colspan="1">0.052 &#x000b1; 0.003 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">98.01</td><td align="center" valign="middle" rowspan="1" colspan="1">2.614 &#x000b1; 0.082</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">2.609 &#x000b1; 0.079</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">16</td><td align="center" valign="middle" rowspan="1" colspan="1">0.286 &#x000b1; 0.034</td><td align="center" valign="middle" rowspan="1" colspan="1">0.287 &#x000b1; 0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.281 &#x000b1; 0.015</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.288 &#x000b1; 0.019</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">17</td><td align="center" valign="middle" rowspan="1" colspan="1">1.249 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">1.247 &#x000b1; 0.063</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.241 &#x000b1; 0.068</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.244 &#x000b1; 0.064</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">18</td><td align="center" valign="middle" rowspan="1" colspan="1">0.298 &#x000b1; 0.011</td><td align="center" valign="middle" rowspan="1" colspan="1">0.292 &#x000b1; 0.018</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.294 &#x000b1; 0.016</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.296 &#x000b1; 0.023</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">19</td><td align="center" valign="middle" rowspan="1" colspan="1">0.676 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0.679 &#x000b1; 0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.671 &#x000b1; 0.029</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.674 &#x000b1; 0.038</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">0.894 &#x000b1; 0.045</td><td align="center" valign="middle" rowspan="1" colspan="1">0.448 &#x000b1; 0.028</td><td align="center" valign="middle" rowspan="1" colspan="1">49.88</td><td align="center" valign="middle" rowspan="1" colspan="1">0.613 &#x000b1; 0.036</td><td align="center" valign="middle" rowspan="1" colspan="1">31.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0.584 &#x000b1; 0.034</td><td align="center" valign="middle" rowspan="1" colspan="1">34.67</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">0.516 &#x000b1; 0.068</td><td align="center" valign="middle" rowspan="1" colspan="1">0.514 &#x000b1; 0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.513 &#x000b1; 0.031</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.517 &#x000b1; 0.041</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.319 &#x000b1; 0.022</td><td align="center" valign="middle" rowspan="1" colspan="1">0.313 &#x000b1; 0.024</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.317 &#x000b1; 0.024</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.314 &#x000b1; 0.021</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">23</td><td align="center" valign="middle" rowspan="1" colspan="1">1.194 &#x000b1; 0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">1.19 &#x000b1; 0.052</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.195 &#x000b1; 0.057</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.192 &#x000b1; 0.051</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">24</td><td align="center" valign="middle" rowspan="1" colspan="1">0.808 &#x000b1; 0.027</td><td align="center" valign="middle" rowspan="1" colspan="1">0.801 &#x000b1; 0.048</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.805 &#x000b1; 0.044</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.81 &#x000b1; 0.046</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">2.249 &#x000b1; 0.069</td><td align="center" valign="middle" rowspan="1" colspan="1">2.245 &#x000b1; 0.069</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.824 &#x000b1; 0.072</td><td align="center" valign="middle" rowspan="1" colspan="1">18.89</td><td align="center" valign="middle" rowspan="1" colspan="1">1.806 &#x000b1; 0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">19.69</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">3.396 &#x000b1; 0.094</td><td align="center" valign="middle" rowspan="1" colspan="1">1.674 &#x000b1; 0.049</td><td align="center" valign="middle" rowspan="1" colspan="1">50.70</td><td align="center" valign="middle" rowspan="1" colspan="1">1.785 &#x000b1; 0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">47.43</td><td align="center" valign="middle" rowspan="1" colspan="1">2.025 &#x000b1; 0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">40.37</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">27</td><td align="center" valign="middle" rowspan="1" colspan="1">0.568 &#x000b1; 0.021</td><td align="center" valign="middle" rowspan="1" colspan="1">0.561 &#x000b1; 0.034</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.567 &#x000b1; 0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.564 &#x000b1; 0.039</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">28</td><td align="center" valign="middle" rowspan="1" colspan="1">0.535 &#x000b1; 0.019</td><td align="center" valign="middle" rowspan="1" colspan="1">0.437 &#x000b1; 0.025</td><td align="center" valign="middle" rowspan="1" colspan="1">18.31</td><td align="center" valign="middle" rowspan="1" colspan="1">0.337 &#x000b1; 0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">37</td><td align="center" valign="middle" rowspan="1" colspan="1">0.081 &#x000b1; 0.006 *</td><td align="center" valign="middle" rowspan="1" colspan="1">84.85</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">0.133 &#x000b1; 0.011</td><td align="center" valign="middle" rowspan="1" colspan="1">0.134 &#x000b1; 0.019</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.136 &#x000b1; 0.026</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">0.132 &#x000b1; 0.011</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">2.989 &#x000b1; 0.083</td><td align="center" valign="middle" rowspan="1" colspan="1">0.348 &#x000b1; 0.023 **</td><td align="center" valign="middle" rowspan="1" colspan="1">88.35</td><td align="center" valign="middle" rowspan="1" colspan="1">1.342 &#x000b1; 0.056</td><td align="center" valign="middle" rowspan="1" colspan="1">55.10</td><td align="center" valign="middle" rowspan="1" colspan="1">1.756 &#x000b1; 0.053</td><td align="center" valign="middle" rowspan="1" colspan="1">41.25</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 25922</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.32 &#x000b1; 0.098</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.796 &#x000b1; 0.085</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.972 &#x000b1; 0.068</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.577 &#x000b1; 0.087</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.34</td></tr></tbody></table><table-wrap-foot><fn><p>* Isolates changed from low-grade positive to biofilm negative after treatment with EOs. ** Isolates changed from highly positive to low-grade positive after treatment with EOs. *** Isolates changed from highly positive to biofilm negative after treatment with EOs.</p></fn></table-wrap-foot></table-wrap></floats-group></article>